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ABSTRACT

Membrane fusion proteins are expressed by many viruses and play a crucial role in fusing
two distinct membranes. Hemagglutinin (HA), the viral fusion protein of influenza, catalyzes
fusion of the viral and target membrane by undergoing a conformational change triggered by a
lowered pH of the endosome. The rearrangement, which is essential for fusion activity, exposes a
highly conserved fusion peptide region. An engineered HA protein, with an altered fusion peptide
region, has a high affinity for the fluorescent ligand, FlAsH. Using the engineered sensing HA,
which allows real time monitoring of open state, we probe for kinetics of the conformational
change.
We report that the engineered sensing HA, with an altered fusion peptide region that was
designed to bind FlAsH after activation, shows induction by FlAsH binding at pH 7.0. The
engineered HA shows activation of the fusion associated conformational change induced by
alternative environmental stimuli compared to the wild-type protein. We suggest a novel
alternative pathway to activation through binding the fusion peptide region which could impact
the treatment of many enveloped viruses. We demonstrate that the engineered sensing HA coexpressed with fusion capable wild-type HA create modular systems that drive fusion triggered
by ligand binding.
We further investigate the role of membrane properties in the activation of HA and the
fusion induced by the viral protein. We show that the depletion of cholesterol leads to a significant
delay in the kinetics of conformational activation and the extent of fusion. We also examine
peptides that alter the membrane and show that disruption leads to the conformational change
v

required for fusion. These results indicate that further studies of the HA behavior in synthetic
membranes with defined phospholipids would be beneficial.
To design new alternative environmental stimuli, we probed the entire HA gene for
potential mutagenesis sites. Creating random mutant libraries and screening for desired phenotypes
we have assessed the amino acids that can tolerate mutations with the help of next generation
sequencing. With a landscape of tolerated mutational positions we can guide future rational design
when trying to engineer the conformational change induced by a new exciting environmental
stimulus.
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CHAPTER 1
INTRODUCTION

1

Engineering novel phenotypes into existing functional proteins has been made possible by
structural information guiding rational designs. Membrane proteins and their role in the transfer of
molecules across the membrane, fluidity, and permeability are an interesting set of proteins that
lend themselves to nanoscale devices. One set of proteins with an interesting mechanism is fusion
proteins found in viruses that catalyze the fusion of two membranes. Creating novel proteins that
would respond to certain signals in a specific environment would lend itself to controlled drug or
gene delivery. Proteins that respond to biological signals irreversibly have also been used as
biosensors. Our goal is to engineer a biological response to ligands, with high sensitivity, and
create a novel protein to initiate the fusion of two membranes. Engineering the influenza virus
machinery, which enables efficient delivery of genetic material, will provide novel biomaterial
that can selectively catalyze fusion.
Our goal is to understand and engineer the process of membrane fusion catalyzed by viral
fusion proteins. Fusion proteins facilitate the combining of two membranes in processes such as
viral infection, secretion, and phagocytosis. Understanding and engineering the mechanism of
viral fusion protein activity will lend insight toward the design of efficient delivery systems for
the transport of drugs, genes, or imaging agents across a membrane. Effective delivery of payloads
to specific cells could influence therapies of many diseases. Hemagglutinin (HA) is a viral fusion
protein that binds receptors on the target cell causing endocytosis of the virosome. Ha then
undergoes an irreversible conformational change upon acidification to catalyze the fusion of
endosomal and viral membranes during influenza infection. The conformational change of
recombinantly-expressed cell surface HA to the fusion active state has been associated with a cellwide autocatalytic activation (Lee, et al., 2006). Other viral fusion proteins go through similar
2

rearrangements in order to deliver viral DNA to the host cell. We propose to study the autocatalytic
mechanism and the cross-talk of viral fusion proteins in the membrane. With the use of deep
sequencing, we furthermore plan to probe for mutation-tolerant residues as well as residues that
play a role in the activation of HA. We also suggest that a novel alternative pathway to activation
can be created by engineering the fusion peptide region of HA and that a ligand binding to this
region can activate the conformational change. This alternative pathway could impact the therapy
of many enveloped viruses. Understanding this novel pathway of activation can lend insight to
more desirable ligands that could activate HA before it is endocytosed, leaving it unable to infect.

Background

Membrane fusion proteins are expressed by many viruses and play a crucial role in fusing
two distinct membranes (Pecheur, et al., 1999). They play a role not only in viral infection but
also in secretion, and phagocytosis. Hemagglutinin is the viral fusion protein of influenza, which
is a membrane-enveloped virus. This virus, like many others, attaches to receptor proteins on the
surface of the target membrane to begin the infection process (Pecheur, et al., 1999). After binding
influenza is internalized by endocytosis. In the endosome HA is triggered into an irreversible
conformational change by the low pH of the acidified endosome which helps overcome the energy
barrier of membrane fusion (Coleman, et al., 2003). The rearrangement, which is essential for
fusion activity, exposes a 20 amino acid sequence, the fusion peptide, which was previously buried
within the protein’s core (Skehel and Wiley, 2000). The fusion peptide is a hydrophobic region
3

which is highly conserved among the subtypes of HA and other class I viral fusion glycoproteins
such as paramyxovirus, human immunodeficiency virus, and human T-cell leukemia virus (Russel,
et al., 2004; Wilson et. al., 2005). Models suggest the insertion of the fusion peptide into the
endosome is a critical step that disrupts the membrane structure (Jahn, et al., 2003). Full length
HA with cleaved fusion peptide region fails to catalyze fusion. Fusion peptides in solution have
been shown to interact with membranes via fluorescence resonance energy transfer experiments
and also cause lysis of liposomes at high concentrations. Several other dramatic conformational
changes such as the protein folding on itself contribute to the proximity of the two distinct
membranes (Shangguan et. al., 1998).
Lipid packing contributes to the destabilization of the target membrane making fusion
more favorable. The energy released by the conformational change helps catalyze the fusion of
the viral membrane and the endosome creating a pathway for the release of its viral RNA into the
cytoplasm of the host cell (Chernomordik, et al., 2008). Several other enveloped viruses, like
human immunodeficiency virus and Moloney murine leukemia virus, have similar hydrophobic
regions that contribute to fusion. They also go through conformational rearrangements in order to
catalyze fusion and allow the release of viral genetic material into the cytoplasm of the host cell
(Hughson, 1997). This makes enveloped viruses such as influenza very efficient at delivering viral
genetic material to hosts cells. Engineering the influenza virus machinery, which enables efficient
delivery of genetic material, will provide new mechanistic understanding, and could lead to novel
biomaterials that can selectively fuse with cells on demand.
HA is a classic model fusion protein and its role in the fusion of influenza’s viral membrane
with the endosome is widely studied (Eckert, et al., 2001; Harrison 2008; White 1990). It is a
4

transmembrane glycoprotein that assembles in a homotrimer made of heterodimer subunits. Each
monomer is synthesized as a single polypeptide chain, HA0, which is cleaved by a protease into
two subunits, HA1 and HA2, held together by a single disulfide link (Carr and Kim 1993; Skehel
and Wiley 2000). The newly formed N-terminus of HA2 contains the fusion peptide in the first
20 amino acids. Following the proteolytic cleavage, the fusion peptide relocates from an exposed
loop into a buried cavity inside the trimeric coiled-coil structure (Cross, et al., 2009).
Hemagglutinin is induced by either a low pH or an increase in temperature. Some models suggest
that protonation of residues in the HA1 head group (Bottcher, et al., 1999; Chen, et al., 1995;
Godley et al., 1992; Huang, et al., 2002; Kemble et al., 1992) destabilize the trimer causing HA to
go through an irreversible conformational change; other models suggest residues in the fusion
peptide and around the cavity where the fusion peptide resides (Cross, et al., 2001; Daniels, et al.,
1985; Lin, et al., 1997; Thoennes, et al., 2008) are responsible for this destabilization in response
to acidic pH. This conformational change exposes the fusion peptide and removes it from the
cavity, relocating it approximately 100 angstroms in the direction away from the viral membrane
toward the target membrane. The fusion peptide in the extended intermediate conformation then
interacts with the target membrane (Figure1.1, all figures located at the end of each chapter). The
extended conformation then collapses bringing the membranes into close proximity. The first
intermediates stage of fusion shared by enveloped viruses is the mixing of lipids where the outer
leaflets merge together while the outer leaflets remain intact, depicted in Figure 1.1.

5

Autocatalytic Activation.
The fusion peptide region of HA was epitope tagged by a previous graduate student in the
lab to enable simple observation of the conformational state by immunofluorescence. An assay
where HA from the fowl plague virus (FPV), an H7N1 antigenic subtype of influenza A
(A/FPV/Rostock/34), is expressed on the surface of mammalian cells where the conformational
change can be detected by immunofluorescent staining (Lee, et al., 2006). With this assay, it has
been demonstrated that the conformational change of HA to the fusion active state is associated
with a cell-wide autocatalytic activation as well as aggregations of the HA on the surface of the
cell. The mechanism of cell-wide communication of HAs on the surface of a cell would suggest
the protein’s interaction with the membrane as a key contributor. Perturbing the lipid packing of
the membrane structure as well as the membrane tension could provide an environment where the
trimers can partially denature and dissociate, which could lead to activation. The aggregation also
seen with autocatalytic activation would also support the need for proximity of activated and nonactivated trimers. The relative timing of both the aggregation and activation is something that
would have to be addressed. Perturbing the membrane environment has been shown to affect the
folded stability of OmpA in bacteria (Hong and Tamm, 2004). Hemagglutinin trimers refolding
can greatly disrupt the membrane structure and tension, which is consistent with a necessary step
in fusion between two membranes. The role that membrane structure and tension has on HA could
provide insight into the mechanisms of other viral fusion proteins.

6

Impacts of Engineered Viral Fusion Proteins.
The use of engineered viral fusion proteins to selectively deliver a payload could provide
advances in efficient delivery of drugs, genes, or imaging agents. We propose engineering a
protein that would allow for the possibility of controlling membrane fusion in response to different
stimuli.

Working with the machinery already in place with viral fusion proteins, we envision

being able to engineer many possible targets that could trigger fusion. Using the cross-talk seen
in autocatalytic activation, we could co-express target sensing proteins, which might not be fusion
active, with fusion active proteins. This would make modular systems that add selectivity to the
delivery of a payload and would create “smart” containers that could potentially deliver payloads
in response to specific markers or specific environments.
In previous work, the fusion peptide region of HA was epitope tagged to enable simple
observation of the conformational change by immunofluorescence. The second half of the residues
in the fusion peptide were replaced with an epitope, c-myc (the mutant HA named HA3.1), which
allows staining and detection of cells expressing HA in a conformationally sensitive manner (Lee,
2007). The fusion peptide is buried within the core of the coiled-coil trimer in its inactive state;
this conformation does not allow for the staining of HA3.1 expressing cells. Once the HA is
activated, the fusion peptide is exposed, and it acts as a detection flag which can now be easily
detected by anti-c-myc antibodies. Only the activated HA can be stained. We can also use a
monoclonal antibody, HC58, to stain in a conformationally sensitive manner.

Monoclonal

antibody HC58 binds only the pre-active state of HA and loses its ability to bind after HA refolds
into its active state (Sugrue, et al., 1990). Using both HC58 and anti-c-myc antibodies, we can
dual stain and simultaneously probe the conformational state of HAs on transfected cells.
7

Transfected cells were pH pulsed and incubated at a certain pH to observe conformational state,
and pH’s in the transition region demonstrated a bimodal response (Lee et. al., 2006). In the
transition pH range, 5.2 -5.4, cells had a cell wide response to activation refolding. At intermediate
pH’s, 5.2 – 5.4, there were no cells with partial levels of c-myc epitope exposure or partial loss of
the HC58 binding (Figure 1.2). There was a mixture of cells with either fully refolded active HA
or full inactive HA.
Fluorescence microscopy data also agreed with flow cytometry data and demonstrated no
single cell with both exposed c-myc tag and ability to bind HC58 (Lee et. al., 2007). Transfected
cells expressing HA3.1 were activated at intermediate pH, similar to the flow cytometry data, and
dual stained with antibody HC58 and anti-c-myc. Cells were exclusively positive for one or the
other antibodies but not both on the same cell (Figure 1.3). Cells that were positive for anti-c-myc,
active state, showed aggregation on the cell surface (Figure 1.4). Cells that were positive only for
the HC58 antibody, inactive state, had no aggregation on the cell surface. Previous studies have
also shown how refolding of HA coincides with aggregation of the trimers (Gutman, et al., 1993;
Chernomordik and Kozlov, 2003).
A model that includes a positive feedback mechanism by which activated trimers promote
the activation of nonactive trimers has been shown to depend on the fusion peptide region (Lee,
2007). Cells expressing HA3.1 at low levels (16 h post transfection) were incubated at pH 5.0
(pulsed) prior to further culturing to allow synthesis and expression of new trimers (Figure 1.5A
& 1.5B). 8 h after the pulse cells showed an increase in HA trimers which were in the activated
state even in the absence of a low pH (Figure 1.5A). New HA trimers expressed after the pulse
spontaneously refolding to activated stated support the model of positive feedback. Treating the
8

HA with thermolysin, which cleaves the fusion peptide region, after the pulse prior to further
culturing abolishes spontaneous refolding (Figure 1.5B) indicating the importance of the presence
of the fusion peptide region for autocatalytic activation. We hypothesize that the fusion peptide,
which is exposed after induction, inserts into its own cell membrane altering the tension and
curvature. As nonactive HA come into the partially denatured membrane environment it leads to
refolding to its active state spontaneously. The idea that membrane environment, modulated by
fusion peptide insertion, contributes to the autocatalytic phenomenon motivates an aim of the
proposed work.
Our lab previously used directed evolution to introduce both stabilizing and destabilizing
mutations into HA. Studies show that the wild-type HA typically is fully refolded by a pH of 5.2
(Daniels et al., 1987; Ilyushina et al., 2007). Novel mutants demonstrating altered activation pH,
previously isolated by our lab, were examined and used to make point mutants to assess the impact
of individual mutations. Point mutants showed ability to alter pH activation in both stabilizing
and destabilizing phenotypes. Point mutants were common in the head group domain indicating
the role those residues play in holding the HA trimer together. The data support a model where
the separation of head group domains leads to activation.
The use of directed evolution with selection on the conformational change did not depend
on maintaining fusion activity or sialic acid receptor binding ability. The receptors on target cells,
sialic acid, bind HA which mediates the initial process of internalization of influenza virus (Sauer
et al., 2014; Leung et al., 2012; Wilks et al., 2012). Sialic acid is a sugar with a nine-carbon
backbone that exits in a variety of conformations. Subtypes of HA have shown to have a specificity
for certain conformations of sialic acid (Wilks et al., 2012). The clones isolated from directed
9

evolution had lost their ability to catalyze fusion. It has been shown that co-expressing altered pH
mutants with wild-type on the same cell creates a modular system that allows the mutated HA, that
activates at a high pH, to function as a trigger to activate a wild-type HA that would normally not
activate at a pH > 5.4 (Lee, 2007). This allows us to engineer HA for other bio-sensing capabilities
without having to maintain the fusion ability. Co-expressing wild type and altered pH HA can be
shown to drive fusion at pH of 5.6 while wild type alone will only drive fusion at a pH < 5.4. The
altered HA mutant acts as a trigger activating signal for the wild-type.

The autocatalytic

phenomenon allows for designing stimulus sensing phenotypes without having to maintain the
fusion capability. With the help of directed evolution, we plan to engineer HA mutants that could
be ligand activated.

Transient Mammalian Expression.
The study of complex function proteins, such as viral fusion proteins, require the use of
eukaryotic cells. Mammalian cell surface display is used in this project for the quantitative
functional analysis of HA. The surface display along with immunostaining allows for the analysis
of the conformational refolding of the protein which is essential for fusion. This tool for
monitoring the conformational change specifically decouples the need to screen for fusion. The
advantage is that tools that monitor refolding via fusion often lose critical information of the
refolding of HA. This same cell surface display is also a crucial tool used in our directed evolution
aim that requires the expression of large libraries and allows us to screen for novel proteins.
In all cases below, unless otherwise stated, HA expression is achieved through the
transfection of CHO-K1 cells. Transfected CHO cells are cultured in selective growth medium,
10

0.85 mg/ml geneticin (Hyclone, Logan, UT), 16 h post-transfection. This allows for a full 24 h
after plasmid is introduced to the cells before selection can begin. The selection at 0.85 mg/ml
geneticin continues for 48 h. Following this selection expression levels of HA on CHO cells are
above 90% 3 days after transfection and around 99% 4 days after (Figure 1.6A). The expression
levels were monitored via immunostaining with mAb HC2, which binds HA in any conformational
state, for the first 4 days (Figure 1.6A). The high expression levels stay consistent when using 0.25
mg/ml geneticin for the following 10 days. Cells used in assays were always selected for at least
4 days and checked for expression. Expression levels drop by 14 days after the transfection (Figure
1.6B). This allows for the use of the transfected CHO cells for at least a week of analysis
experiments.

11

Appendix

Figure 1.1. Fusion induced by viral fusion proteins. Events of HA refolding that catalyze
membrane fusion. (a) Prefusion conformation with the fusion peptide (light green) pointing away
from target cell membrane representing inactive state. (b) Extended intermediate. Protein refolds,
extending the fusion peptide to interact with the target membrane. (c) Collapse of extended
intermediate. C-terminal segment of the protein folds back along the outside of the trimer core.
The segments from the three subunits fold back independently, the trimer can bow outward, away
from the deforming membrane. (d) Hemifusion. When collapse of the intermediate has proceeded
far enough to bring the two bilayers into contact, the apposed, proximal leaflets merge into a
hemifusion stalk. Figure reprinted from Harrison, 2008, with permission from Nature publishing
group.
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Figure 1.2. Conformational change of hemagglutinin (HA). (A) Ribbon diagram of HA
metastable conformation before activation. (B) Cartoon diagram of HA refolding triggered by
induction step (pH or temperature) (C) Changes in HA2 subunit after induction (HA1 not shown).
HA2 residue Cys137 forms the only disulfide bond with a Cys in subunit HA1 to tether the
subunits. The 39 residues on the N-terminal are not observed on the structure on the right.
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Figure 1.3. Autocatalytic conformational change. Cells expressing HA mutant with c-myc
epitope were incubated at indicated pH for 5 min. Cells were co-stained with HC58 and anti-cmyc. At intermediate pH’s (5.4 and 5.2) cells show staining for only one of the antibodies,
demonstrating a fully active or fully inactive HA profile. Figure reprinted from Lee et. al., 2007,
with permission from Elsevier publishing.
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Figure 1.4. Aggregation of activated cells. Cells expressing HA mutant with c-myc epitope was
incubated for 5 min at pH 5.4 and co-stained with biotin-HC58/streptavidin-FITC and 9E10/antimouse TRITC. Inverted fluorescence microscope at 40x magnification and Image J was used to
analyze the images. Figure reprinted from Lee et. al., 2007, with permission from Elsevier
publishing.
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Figure 1.5. Autocatalytic activation dependence on fusion peptide. Cells expressing HA3.1
were analyzed at 16 h and 24 h post transfection. (A) Cells were pulsed at a pH 5.0 and labeled
with c-myc. Additional 8 h of culturing and analyzed with (P: +) and without (P: -). (B) Cells were
pulsed at a pH 5.0 and labeled with c-myc. Treated with thermolysin to cleave fusion peptide prior
to further culturing. Additional 8 h of culturing and analyzed with (P: +) and without (P: -). Figure
reprinted from Lee et. al., 2007, with permission from Elsevier publishing.
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Figure 1.6. Transient transfection selection. CHO cells were transfected with plasmid
containing HAcmyc and analyzed for expression using mAb HC2. A gate showing the expressing
cell population was drawn based on non-transfected CHO cells as negatives. (A) The expression
levels were monitored at 48 h (red), 72 h (blue), and 96 h (green). Cells maintain a high expression
level for 10 days after transfection. (B) 14 days after transfection the population of cells expressing
HA has dropped.
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CHAPTER 2
LIGAND INDUCTION AND MODULAR SYSTEMS

18

Abstract

Here we report that an engineered sensing HA, bearing an altered fusion peptide region
designed to bind to a fluorescent ligand (FlAsH) after activation, shows induction by FlAsH
binding at a neutral pH. We suggest a novel alternative pathway to activation through binding the
fusion peptide region which could impact the therapy of many enveloped viruses. Furthermore,
we demonstrate that the engineered sensing HA loses its fusion function, but co-expression with
fusion capable wild-type HA create modular systems that drive fusion triggered by ligand binding.
Modular systems can potentially be engineered to drive fusion triggered by a variety of
environmental stimuli which can benefit the design of efficient drug or gene delivery.

Methods and Materials

Plasmids.
Fowl plague virus (A/FPV/Rostock/34) HA gene (Lin et al. 2001) was digested with XhoI
and NotI and ligated into the retroviral expression vector pLNCX2 (Clontech, Mountain View,
CA). Overlap extension PCR was used to replace fusion peptide residues 13-18 (amino acids 355360) with a tetra-cysteine tag (CCPGCC) and ligated into pLNCX2 (Clontech), herein referred to
as HA4xCys or HA4.4. A previously created HA mutant with a c-myc epitope tag sequence
(EQKLISEEDL) cloned into the fusion peptide residues 11-20 (amino acids 353 – 362) was also
ligated into the pLNCX2 (Clontech) vector (Lee et al. 2006), herein referred to as HAcymc. A T7
19

bacteriophage promoter was cloned into the promoter region of pMCS-Red Firefly Luc (Pierce,
Rockford, IL) plasmid. The red firefly Luciferase gene under the control of the T7 bacteriophage
promoter was digested with XhoI and NotI and ligated into the retroviral vector pLNCX2. A
mammalian expression vector with a T7 RNA polymerase insert, pCAG-T7pol was used to express
the polymerase in the target cells, BHK-21. The plasmid pCAG-T7pol was a gift from Ian
Wickersham (Addgene plasmid # 59926). All DNA manipulations were performed in E. coli
Top10 or DH5α and cultured in Luria broth (LB; 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl)
supplemented with ampicillin at 50 µg/ml.

Cell Culture.
CHO-K1 cells (ATCC CCL-61) and BHK-21 cells (ATCC CCL-10) were cultured in
Dulbecco’s Modified Eagles Medium: Kaighn’s Modification of Ham’s F-12 (DMEM:F-12K) and
Eagle’s Minimum Essential Medium (EMEM), respectively. Both media were supplemented with
10% fetal bovine serum (FBS) (Hyclone, Logan, UT), 100 µg/ml penicillin and 100 µg/ml
streptomycin (Life Technologies, Grand Island, NY). CHO-K1 cells were transfected with
plasmids using Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA) according to
manufacturer’s protocol. CHO-K1 cells were also used as effector cells in the fusion assay’s, they
were co-transfected with HA and a luciferase reporter plasmid under the control of T7
bacteriophage promotor. Transfected CHO cells were cultured in selective growth medium, 0.85
mg/ml geneticin (Hyclone, Logan, UT), 16 h post-transfection and selected for 48 h before any
assay. After first 48 h selection 0.25 mg/ml geneticin was used to grow cells and maintains ~100%
expression for 1 week. All transfections of CHO cells followed the same selection process. CHO20

K1 cells were used to surface express HA wild type and mutants in all assays, except where
indicated otherwise. BHK-21 cells were transfected, using Lipofectamine 2000, with T7 RNA
polymerase plasmid and used as target cells in fusion assays.

Analysis of Induced HA.
All adherent cells were detached using 0.05% trypsin-EDTA (Hyclone) and aliquoted into
1.5mL microcentrifuge tubes and placed on ice. Cells were washed twice with PBSA and pelleted
at 800xg using a benchtop microcentrifuge. The cells were then exposed to a pH induction step
using citrate buffer at appropriate pH for 5 min at room temperature or a FlAsH induction step by
addition of FlAsH buffer containing 2.5 µM FlAsH-EDT2 and 0.25 µM 1, 2-ethanedithiol (EDT)
in serum free 1:1 DMEM:F-12K media, for 15 min at room temperature. The TC-FlAsH in cell
tetra-cysteine tag detection kit (Molecular Probes # T34561, Eugene, OR) was used and optimized
according to the manufacturer’s recommendations. After the induction step, the cells were
immunofluorescently stained and assayed by flow cytometry.

Cell surface expression was

determined by monoclonal antibody (mAb) HC2 immunofluorescent staining, and HA
conformation was determined by pre-activation specific monoclonal antibody HC58 (Sugrue et.
al, 1990) staining, along with secondary antibodies of appropriate specificity. A previously shown
mutant, HAcmyc, was used to monitor the activated state by staining with mAb 9e10 (Lee et al
2006).

21

Fusion Assays.
For a qualitative syncytium assay, CHO-K1 cells transfected with HA were used as effector
cells. CHO-K1 cells either expressed only wild type HA or only tetra-cysteine HA mutant
HA4xCys or co-expressed wild-type HA and HA4xCys due to co-transformation. Un-transfected
BHK-21 cells were stained with PKH26 (Sigma-Aldrich, Saint Louis, MO), a membrane labeling
dye, according to manufacturer’s protocol, and used as the target cells. CHO cells co-expressing
different combinations of HA were then mixed at a 1:1 ratio with BHK-21 target cells. The mixture
was then exposed to an induction step for 15 min at a neutral pH in FlAsH buffer, 2.5 µM FlAsHEDT2 and 0.25 µM EDT in serum free DMEM:F-12K media or citrate buffer at appropriate pH
for 5 min. Negative FlAsH buffer contains no FlAsH-EDT2 and 0.25 µM EDT in serum free 1:1
DMEM:F-12K media. After the FlAsH incubation, the cells were spun down and re-suspended in
full media (DMEM:F-12K supplemented with 10% fetal bovine serum and 100 µg/ml penicillin
and 100 µg/ml streptomycin) and then incubated in an Eppendorf tube for 30 minutes to allow for
syncytia formation. Syncytia formation was observed using Nikon Eclipse Ti (Nikon, Melville,
NY) inverted microscope with an attached camera.
A quantitative cell fusion assay using a luciferase reporter (Byrd-Leotis et. al., 2015) was
used to assess HA-mediated membrane fusion. CHO cells were transfected with HA plasmid and
a plasmid containing Red Firefly Luciferase gene (Pierce) under the control of a T7 bacteriophage
promoter using Lipofectamine 2000 (Invitrogen) according to manufactures protocol to create
effector cells. 16 h post-transfection, the effector cells were placed in selective growth medium
containing 0.85 mg/ml geneticin (Hyclone) for 48 h. Target BHK-21 cells were transfected with
pCAG-T7, a plasmid containing T7 bacteriophage polymerase under the control of a constitutive
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promoter, also using Lipofectamine 2000. pCAG-T7 pol was a gift from Ian Wickersham
(Addgene plasmid # 59926). 48 - 72 h after transfection of the target cells, the HA-expressing cells
were washed with PBS and treated with 0.05% trypsin-EDTA (Hyclone). The CHO effector cells
were then overlaid on the target cells and incubated for 1 h at 37 ˚C to allow cells to adhere. Cells
were washed once with PBS (Hyclone) and then exposed to appropriate induction buffer for 5 or
15 min. At the end of the induction complete growth medium was added to neutralize the reaction.
The cells were incubated for 6 h at 37 ˚C to allow for cell-cell fusion and plasmid transfer leading
to expression of luciferase. The cells were then washed once with PBS and lysed with 0.1 ml of
lysis buffer (Pierce) and incubated in a 37 ˚C shaker for 15 min. 20 µl of lysate was transferred to
a 96-well plate and 50 µl of D-luciferin substrate and 1 µl of Firefly signal enhancer (Pierce) were
added to each well. Luciferase-catalyzed luminescence resulting from cell fusion was quantified
using a Bio-Tek Synergy 2 multi-mode plate reader (Bio-Tek, Winooski, VT).

Results

Ligand (Flash) Binding.
To build a system allowing us to simultaneously assess the conformational rearrangement
and aggregation of HA, we introduced a tetra-cysteine tag in the fusion peptide region. The tetracysteine peptide, CCPGCC, was cloned into the fusion peptide region (see Methods) of HA. The
tetra-cysteine sequence can bind the fluorescent dye 4’,5’-bis(1,3,2-dithiarsolan-2-yl)fluorescein
(FlAsH), which fluoresces only upon binding the 6-amino acid sequence, potentially allowing the
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use of real-time microscopy to monitor the kinetics of conformational rearrangement and
subcellular localization (including aggregation) of HA upon activation (Griffin et. al., 1998).
HAcmyc, which similarly has a c-myc epitope tag in the fusion peptide region of HA, was used as
a negative control due to its lack of binding to FlAsH. CHO cells were transfected with either tetracysteine or c-myc HA and subjected to selection described in the methods. FlAsH buffer was added
to cells expressing the two different HA mutants and analyzed for fluorescence. Microscopy
analysis showed dye binding the tetra-cysteine mutant (named HA4xCys), which indicates
activation of hemagglutinin, even in the absence of low pH when incubated with FlAsH buffer.
Both samples of HA4xCys incubated with FlAsH buffer at pH 5 and neutral pH showed similar
fluorescence and the negative control, HAcmyc, showed no significant fluorescence.
To analyze the kinetics of ligand binding, we used CHO cells transfected with either
HA4xCys or HAcmyc. We analyzed CHO cells transfected with HA4xCys for ligand binding by
inducing with a FlAsH buffer containing FlAsH-EDT2 at different concentrations and 0.25 µM
EDT in a HEPES buffered serum free 1:1 DMEM:F-12K media, for 15 min at room temperature.
After the induction cells were stained with mAb HC58, which binds only the inactive state of HA,
and analyzed via flow cytometry. CHO cells expressing HA4xCys and induced with FlAsH buffer
demonstrated the loss of HC58 binding only at 2.5 µM FlAsH (Figure 2.1). The loss of HC58
binding indicates that the HA has gone through the conformational change. Negative FlAsH buffer,
which has no ligand but still contains 0.25 µM EDT in serum free 1:1 DMEM:F-12K media, and
0.25 µM FlAsH have a higher HC58 fluorescence than the negative control which indicates the
HA is still in the inactive state (Figure 2.1). Kinetic data, analyzed with flow cytometry, shows a
delay in fluorescence prior to the induction with FlAsH buffer followed by a rapid increase in
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fluorescence after 7 min for HA4xCys (Figure 2.2A, blue), whereas the control HAcmyc (Figure
2.2A, black) shows no increase in fluorescence after 7 min. This suggests that binding of the ligand
in the absence of a low pH is potentially causing the conformational change. This data also agrees
with microscopy data of the same two samples. CHO cells expressing HA4xCys and negative
control CHO cells expressing HAcmyc both had a small increase in fluorescence at 1 min prior to
FlAsH incubation but only the HA4xCys cells has a rapid increase after 7 min (Figure 2.3).

Ligand Induced Conformational Change.
To monitor conformational change a previously developed assay using immunofluorescent
staining and flow cytometry was used (Lee et al. 2006). Monoclonal antibody (mAb) HC58, which
binds only the pre-activation trimer conformation, was used to stain HA (Sugrue et al. 1990). CHO
cells transfected with either HA4xCys or HAcmyc were exposed to an induction step, stained with
HC58, and analyzed with flow cytometry. Using a mock FlAsH- buffer induction step (no FlAsH
present) at pH 7.0 for 5 min, both samples retained the ability to bind HC58 (Figure 2.2 Column
B). An induction step with the FlAsH+ buffer for 15 min caused only the HA4xCys CHO cells to
go through the conformational change and lose the ability to bind HC58 (Figure 2.2 Column C).
An induction step at pH 5.2 for 5 min, which has been shown by previous assays to cause wildtype H7 HA to undergo a conformational change to its active state, caused both the HA4xCys and
HAcmyc (negative control) to lose HC58 binding (Figure 2.2 Column D). Demonstrating that the
FlAsH buffer at a neutral pH causes the same reaction in HA4xCys that a low pH would cause in
any HA. The fluorescent ligand (FlAsH dye) presumably binds the tetra-Cys tag in the preactivation state, changes its position, and destabilizes the conformation, allowing the HA timer to
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refold to the activated conformation. This novel alternative pathway to activation suggests it may
be possible to create fusogenic HA proteins responding to a variety of stimuli, provided they can
be engineered for ligand binding to the fusion peptide region.
The ligand binding reaction was buffered to prevent a change in the pH. The organoarsenics found in FlAsH-EDT2 create a reversible covalent bond with pair of thiols. The design of
the tetra-cysteine peptide, CCPGCC, provide a cooperative and favorable reaction for the arsenics
(Griffin et al., 1998; Pomorski et al., 2011). A HEPES buffer at a significantly higher concentration
was used to preclude the possibility of the reaction producing enough protons to change the pH.
We cannot exclude the possibility of a micro-environment of low pH created by FlAsH binding,
but the overall pH of the buffer should not be change due to the 15mM HEPES buffer.

Autocatalytic Crosstalk.
The cell-wide autocatalytic activation of HA’s conformational change allows us to create
modular systems where HA’s communicate (crosstalk) with each other (Lee et al. 2006). Modular
systems where HA’s with sensing capabilities (ligand activating) can activate co-expressed HA’s
with a fusion phenotype allow us to engineer HA without having to retain fusion function. The
HAcmyc mutant, which was shown not bind FlAsH previously, was co-expressed with HA4xCys
(sensing HA). Co-expressed cells were exposed to an induction step then stained with mAb 9e10
which binds only the HAcmyc that has gone through a conformational change to the active state.
Flow cytometry data shows cells co-expressing tetra-cysteine and c-myc mutants demonstrated
full activation of HA trimers in the presence of FlAsH at a neutral pH (Figure 2.4C) and no
activation is seen using the mock FlAsH buffer induction (Figure 2.4B). This suggests that trimers
26

activated by FlAsH can activate c-myc trimers through autocatalytic crosstalk. To further test
crosstalk we transfected CHO cells with both HAcmyc and HA4xCys mutants at different plasmid
ratios (HAcmyc: HA4xCys) keeping the total amount of plasmid the same. The transfected cells
were then exposed to an induction step of either pH 5.2 for 5 min, mock FlAsH buffer at pH 7.0
for 15 min, or FlAsH buffer for 15 min then analyzed by flow cytometry as described above in the
methods. This assay suggests that HA4xCys mutants activated by FlAsH binding the fusion
peptide region can activate c-myc trimers through autocatalysis. Activated HAcmyc would allow
us to monitor the conformational change indicated by c-myc signal, median fluorescence intensity
(MFI), via immunofluorescent staining with mAb 9e10 and flow cytometry (Figure 2.5). The
median fluorescence intensities were normalized with negative and positive controls as described
in Figure 2.11. Ratios 1:2, 2:1, 5:1 show an increase in c-myc MFI and support the idea that trimers
made up of only HAcmyc can be activated by autocatalysis (Figure 2.5). At the ratio of 10:1, which
doesn’t agree with statistical analysis shown in Figure 2.6, we see a drop in the c-myc signal when
we expected it to keep increasing along with the sample that was induced with low pH (Figure
2.5). This may be due to the density dependence of HA to undergo its conformational change. The
low surface density of HA trimers that are activatable by FlAsH may need a longer induction time
to observe a larger signal. The signal that we are observing could be due to the cells that are
expressing higher amounts of FlAsH inducible trimers. Statistical analysis suggests that
heterotrimers are not solely responsible for the c-myc fluorescence signal (Figure 2.6). The level
of c-myc signal is significantly higher, more so than the cells induced with low pH, than what we
would expect if only mixed trimers were induced. Theoretically, there are four possible trimer
combinations when transfecting with two different HA: all HAcmyc, all HA4.4, or two distinct
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heterotrimers (1 HAcmyc:2 HA4.4 and 2 HAcmyc:1 HA4.4). If only heterotrimers, trimers made
up of a combination of HA4.4 and HAcmyc, were responsible for our c-myc signal then we would
expect a drop-in MFI at the 5:1 ratio which was not observed (Figure 2.5). More experiments are
needed to determine the ratio of expression levels of the two mutants. Crosstalk allows us to
potentially create systems in which co-expressing HA’s engineered for novel sensing functions
with fusion capable HA (wild type) could make modular fusogenic systems that are triggered by
alternative stimuli.

Syncytia Formation.
To test modular fusogenic systems we co-transfected with HA4xCys and wild- type HA
(wtHA) and tested for qualitative syncytium formation via microscopy. A syncytium is a
multinucleated cell that forms from multiple cells fusing together. Qualitative syncytia assays have
been used to monitor fusion in both influenza and human immunodeficiency viruses (Byrd-Leotis,
et al., 2015; Huerta et. al., 2009). The fusion mechanism pathway contains an intermediate stage
where the outer contacting lipid leaflets merge while the inner leaflet remains intact, called
hemifusion (Chernomordik et al., 2006; Jahn et al., 2006; Podbilewicz et al., 2006; White et al.,
2008). The intermediate stage of hemifusion allows for the staining of the membrane and
monitoring of the dye transfer to indicate the beginning steps of fusion. CHO cells expressing HA
(effector cells) were incubated with target cells, subjected to different induction steps, and
analyzed for syncytium formation. Un-transfected BHK-21 cells stained with PKH26 (SigmaAldrich), a membrane labeling dye, were used as our target cells. The effector cells were exposed
to an induction step of either 15 min at a neutral pH FlAsH buffer or 5 min pH 5.2 citrate buffer.
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After the induction step, the cells were spun down and re-suspended in full medium and then
incubated in an Eppendorf tube with target cells, PKH26 stained BHK-21 cells, for 30 min to allow
for syncytia formation and PKH26 dye transfer which was visualized and photographed using
Nikon Eclipse Ti inverted microscope with an attached camera. Syncytia formation and a
dispersed PKH26 dye, indicating transfer, was observed at a neutral pH with the FlAsH induction
when both tetra-cysteine and wild-type HA are co-expressed (Figure 2.7C). Similarly, effector
cells expressing wild-type HA showed both syncytium formation and dye transfer (Figure 2.7B).
Effector cells expressing only tetra-cysteine mutant and induced with FlAsH showed ligand
binding but showed no syncytium formation or PKH26 dye transfer (Figure 2.7D). This was
expected due to the tetra-cysteine peptide being cloned into a conserved fusion peptide region and
other studies that show the loss of fusion activity due to single point mutants in this region (Li 05).
Even though the FlAsH-sensing HA could undergo the fusion associated conformational change,
the tetra-cysteine mutation caused a loss of syncytium formation capability. Co-expressing the
tetra-cysteine mutant with a fusion capable wild-type HA allowed for the recovery of syncytium
formation triggered by ligand binding in our modular system. The syncytium assay coincides with
the flow cytometry data showing activation of non-FlAsH binding HA co-expressed with tetracysteine HA in the presence of ligand.

Quantitative Assessment of HA-mediated Fusion.
We also tested the modular system’s ability to drive fusion using a quantitative luciferasebased assay. The luciferase assay allows us to obtain a qualitative measurement that corresponds
to luciferase activity to monitor fusion. The effector cells, expressing HA and carrying luciferase
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plasmid, ability to transfer plasmid encoding firefly luciferase under the control of T7
bacteriophage promoter to target cells expressing T7 bacteriophage polymerase are an indirect
measure to indicate fusion (Byrd-Leotis et al. 2015, Figure 2.8). To test the modular systems ability
to drive fusion we examined the wild-type HA and 3 mutants (W243S, G237R, and G365C) which
all activate at a higher pH than the wild-type (Figure 2.9). The destabilized mutants were isolated
from directed evolution work and characterized using immunostaining and flow cytometry done
previously in our lab. CHO cells were first transfected with only 1 HA plasmid and plasmid
containing Red Firefly Luciferase gene under the control of a T7 bacteriophage promoter using
lipofectamine. BHK-21 cells expressing T7 bacteriophage polymerase were used as target cells.
The wild-type HA was able to drive fusion at a pH 5.43 (Figure 2.9A) but none of the three mutants
were able to drive fusion when expressed alone (Figure 2.9B, 2.9C, 2.9D ▲). The relative
luminescence unit was normalized as described in Figure 2.12. CHO cells co-expressing the
mutant HA and wild-type (Figure 2.9B, 2.9C, 2.9D ●) were used as effector cells with the same
target cells as before. When the mutants were co-expressed with a fusion capable wild-type it
showed the ability to drive fusion at a higher pH which correlated with the destabilized mutant’s
refolding pH. The data was fitted to a dose response curve with variable slope as described in
Figure 2.13.
CHO cells (effector cells) were transfected with both HA4xCys and wild-type HA as well
as a firefly luciferase gene under the control of a T7 bacteriophage promoter (Pierce, Rockford,
IL). Effector cells expressing only HA4xCys mutant was used as a negative control due to its loss
of forming syncytia. Target BHK-21 cells were transfected with pCAG-T7, a plasmid to express
T7 bacteriophage polymerase but were not subject to any selection. pCAG-T7pol was a gift from
30

Ian Wickersham (Addgene plasmid # 59926). CHO effector cells were overlaid on BHK-21 target
cells then exposed to a FlAsH buffer induction step for 15 min at different concentrations of FlAsH
keeping the other buffer concentrations the same (Methods for further detail). After neutralization
of the FlAsH buffer, sufficient incubation time was allowed for fusion and plasmid transfer leading
to expression of luciferase. Lysates were analyzed for bio-luminescence activity of Luciferase
using a Bio-Tek Synergy 2 plate reader. The modular system induced by FlAsH demonstrates
fusion comparable to wild-type effector cells induced by pH 5.2 at FlAsH concentrations ≥ 2.5 µM
after the data was normalized as described above (Figure 2.10). Fitting a dose response curve
with variable slope to our titration data indicates an EC50 of 1.04 µM FlAsH (Figure 2.10 & Figure
2.14). Effector cells expressing only HA4xCys showed no luciferase activity which was expected
given that the highly conserved fusion peptide region was mutated (Figure 2.10). The modular
system tested with both the luciferase assay and the syncytium assay are in agreement. Taken
together, we show the capability of modular systems that are triggered by alternative stimuli to
drive fusion even if the sensing HA is unable to induce membrane fusion. Fusogenic modular
systems can co-express HA’s engineered for a variety of novel sensing functions with HA’s that
contain an actuating component.

Discussion

A broader understanding of the general mechanisms of fusion can lead to more efficient
therapy of many enveloped viruses. The novel alternative pathway that we suggest here of
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activation through binding the fusion peptide region provides the potential to target a highly
conserved region found in all subtypes of HA. The fusion peptide also has common motifs found
in other class I viral fusion glycoproteins such as paramyxovirus, human immunodeficiency virus
(HIV), and human T-cell leukemia virus (Russel et al., 2004; Wilson et. al., 2005). There has also
been literature that suggests the stability of HA is influenced by the residues in the fusion peptide
and the fusion peptide pocket, a cavity where the peptide forms extensive contacts in the preactivation state (Cross et al., 2001; Ilyushin et al., 2007; Thoennes et al., 2008; White et al., 2016).
The FlAsH dye presumably binds the tag in the pre-activation state and destabilizes it, allowing
the HA timer to refold to the activated conformation. Potential therapies can be envisioned where
activation of HA on the virion by ligand binding prior to endocytosis would render the virus unable
to infect. It’s been shown that pretreatment of influenza virus before a target cell is present leaves
the virus enable to infect (Markovic et al., 2001; Leikina et al., 2002; Gutman et al., 1993). The
extent of inactivation has also been observed to depend on the strain and the difference in
inactivation attributed to the difference in kinetics (Markovic et al., 2001)
The trimers activated by FlAsH can activate non-ligand binding trimers through an
autocatalysis which can potentially arise from effects mediated by locally altered membrane
structure and tension. The model for autocatalysis has been proposed and the dependence of this
phenomena on the fusion peptide was shown that by treatment with thermolysin which cleaves the
fusion peptide (Lee et al., 2006). The initial reversible conformational change of HA upon
acidification or ligand binding removes the hydrophobic fusion peptide from the cavity. The
mechanism of cell-wide communication of HAs on the surface of a cell would suggest the protein’s
interaction with the membrane as a key contributor. Previous work has shown how the fusion
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peptide can cause perturbations in the membrane (Harrison et al., 2015; Ivanovic et al., 2013).
Perturbing the lipid packing of the membrane structure as well as the membrane tension could
provide an environment where the trimers can partially denature and dissociate, which could lead
to activation. Perturbing the membrane tension has been shown to affect the folded stability of
OmpA in bacteria (Hong and Tamm, 2004). Another membrane perturbing peptide, the 42 amino
acid fragment of β-Amyloid, has been shown to have antiviral activity with two strains of influenza
in vitro presumably by causing viral aggregation or altering the viral membrane (White et al.,
2014). Hemagglutinin trimers refolding can greatly disrupt the membrane structure and tension,
which is consistent with a necessary step in fusion between two membranes. The role that
membrane structure and tension has on FPV HA could provide insight into the mechanisms of
other viral fusion proteins which undergo a similar conformational change. Our proposed model
for the membrane being a key contributor to crosstalk could potentially be applied to other viral
fusion proteins.
The crosstalk of two distinct HA’s allows us to create modular systems where sensing HA
can refold due to a novel stimulus which would then trigger an HA with an actuating component
depicted in Figure 2.11. Potential fusogenic modular systems can provide selectivity to delivery
systems. Both of our syncytium and luciferase fusion assays suggests the potential to create these
modular fusogenic systems. The sensing mutant, HA4xCys, is triggered by ligand binding to
undergo its fusion associated conformational change but is unable to induce fusion when expressed
alone. Engineering of the fusion peptide region to bind a variety of stimuli could provide novel
sensing functions while not having to retain the fusion capability. The sensing HA co-expressed
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with a fusion capable HA, such as wild-type, would create a fusogenic systems that would be
induced in specific environments.
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Appendix

Figure 2.1. Activation of mutant HA with ligand (FlAsH). CHO cells were transfected with
HA4xCys plasmid, induced with different concentrations of FlAsH buffer, and analyzed by flow
cytometry. The induction step with indicated FlAsH buffer was performed for 15 min (based on
microscopy data) and then staines with HC58 (which binds inactive conformation of HA). Black
curve on histogram indicate un-transfected CHO cells, green curve are cells induced with mock
FlAsH buffer ( 0 µM FlAsH), red curve are cells induced at 0.25 µM FlAsH, blue curve are cells
induced at 2.5 µM FlAsH .
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Figure 2.2. Binding and activation of mutant HA with ligand (FlAsH) induction. (A) CHO
cells were transfected with HA4xCys (blue) or negative control HAcmyc (black) and analyzed
with flow cytometry. Flash buffer at neutral pH was added at t = 0. Multiple samples were tested
for ligand binding starting every min. The graph only shows fluorescence of both samples starting
at t = 420 s. (B-D) CHO cells were transfected, induced, and analyzed by flow cytometry. Black
curves on histograms indicate un-transfected CHO cells, blue curves are CHO cells transfected
with HA c-myc, and green curves are CHO cells transfected with HA 4xCys. All staining was
performed with mAb HC58 which binds inactive conformation of HA. (Column B) Cells are
pulsed at indicated pH for 5 min and stained with HC58. Both top and bottom show fluorescence
higher than negative which indicates inactive HA. (Column C) Cells are pulsed at indicated pH
with FlAsH buffer for 15 min and stained with HC58. Top shows HA c-myc (negative control)
fluorescence is higher than un-transfected CHO cells indicating inactive HA. Bottom shows cells
expressing HA 4xCys with similar fluorescence as un-transfected CHO cells which indicates
FlAsH induced conformational change. (Column D) Cells are incubated at pH 5.2 for 5 min and
stained with HC58. Both top and bottom have similar fluorescence to un-transfected cells which
indicates low pH induced both samples.
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Figure 2.3. Ligand binding kinetics. CHO cells were transfected with HA4xCys and analyzed
via microscopy. CHO cells transfected with HAcmyc were used as a negative control. FlAsH
buffer was added at t = 0 sec and fluorescence was monitored. A slight increase was seen after 1
min that is also seen in the negatives control which we attribute to background. After 7 min a rapid
increase is seen in the CHO cells expressing HA4xCys. The entire assay is done at a neutral pH.
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Figure 2.4. Crosstalk between HA trimers. (A) Diagram showing FlAsH dye inducing
conformational change of HA 4xCys monomer. Crosstalk between trimers activate non-HA 4xCys
monomers. (B-D) Black curves are un-transfected CHO cells and blue curves are CHO cells
transfected with both HA 4xCys: HA c-myc at 1:5 ratio. (B) Cells are incubated at indicated pH
for 15 min with no FlAsH and stained with anti-c-myc. Blue curve overlaps the negative control
indicated no activation. (C) Cells are incubated at indicated pH for 15 min with FlAsH and stained
with anti-c-myc. Blue curve shows higher fluorescence than negative indicating that non-4xCys
HA monomers were triggered with dye. The graph indicates two populations of expressing cells
that are both positive for c-myc signal. The higher intensity population are cells expressing at a
higher level which is the smaller peak (D) Cells are incubated at indicated pH for 5 min and stained
with anti-c-myc. Blue curve shows higher fluorescence than negative showing that low pH can
trigger the conformational change. It is presumed that the higher expressers are lost in this graph
due to the low pH being more stressful than the ligand induction and lysing the cells.
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Figure 2.5. Crosstalk of HA3.1 : HA4.4 at different ratios. CHO cells were transfected at 1:2,
2:1, 5:1, and 10:1. The cells were then activated by pH 5.2 (▲), pH 7.0 (●), or FlAsH (■). The cmyc signal was monitored by immunostaining and flow cytometry. Median Fluorescence was
calculated for 3 independent experiments with the standard deviation as error bars. Normalized
using CHO cells transfected with only HAcmyc plasmid.
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Figure 2.6. Probabilistic analysis of heterotrimers. The probability of heterotrimers, trimers
made up of a combination of HA4.4 and HAcmyc, are shown in the table. Only HAcmyc
monomers (blue circles) would show a fluorescence signal when stained with mAb 9e10. Columns
with single, double, and triple HAcmyc monomers were multiplied by 1, 2, or 3 respectively to
predict a relative fluorescence. (A) Crosstalk of HA3.1 : HA4xCys at different ratios. CHO cells
were transfected at 1:2, 2:1, 5:1, and 10:1. The cells were then activated by pH 5.2 (▲), pH 7.0
(●), or FlAsH (■). The c-myc signal was monitored by immunostaining and flow cytometry.
Median Fluorescence was calculated for 3 independent experiments. Normalized to CHO cells
transfected with only HAcmyc plasmid. (B) Relative fluorescence predicted by statistical analysis
for 1:2, 2:1, 5:1, and 10:1 ratios (HAcmyc : HA4.4). Predicted relative fluorescence for two
different scenarios are shown. The two scenarios are if only heterotrimers are activated (▼) and if
all trimers (including HAcmyc homotrimers) are activated (●).
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Figure 2.7. Syncytia formation indicating fusion. Column 1 is a bright field image in which we
are looking for multicell sized formations to indicate fusion. Column 2 and column 3 are images
of PKH26 and FlAsH stains respectively. Column 4 is an overlay of column 2 and 3. In all cases
the same BHK-21 stained with PKH26 were used as target cells. (Row A) Un-transfected CHO
cells are incubated for 5 min at 5.2 pH then incubated with target cells. No syncytia formation
was observed. (Row B) Cells transfected with HA WT and triggered by 5 min incubation at pH
5.2. First box shows syncytia formation. Second box shows a more dispersed PKH26 dye
indicating transfer of dye. (Row C) Cells transfected with both HA WT and HA 4xCys at 1:1 and
incubated with FlAsH. First box shows syncytia formation. Second and third box show a dispersed
stain of both PKH26 and FlAsH. Fourth box is an overlay done with Image J. Overlapping red
and green dye indicates coincidences of syncytia formation and dye transfer. (Row D) Cells
transfected with HA 4xCys incubated with FlAsH showed no syncytia formation.
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Figure 2.8. Quantitative cell fusion assay. Delivery cells expressing HA and carrying plasmid
with red firefly luciferase gene under the control of T7 polymerase are overlaid on target cells.
Target cells express the T7 polymerase. An activation step is used to induce fusion. After the
activation step the cells are neutralized to non-activating conditions and sufficient time is allowed
for fusion of effector and target cells as well as the transfer and expression of the T7 luciferase
plasmid for the expression of luciferase protein. The bio-luminescence of the lysates are analyzed
for successful fusion. The activity of luciferase when it reacts with D-Luciferin will indirectly
indicate fusion.
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Figure 2.9. Quantitative cell fusion assay of wild-type and mutants. Effector cells contain red
firefly luciferase gene under control of T7 polymerase and express either one or two HA proteins.
Target BHK-21 cells expressing T7 polymerase. Effector cells are overlaid onto target cells and
incubated at specific pH for 5 min. After neutralization 6 h incubation is given to allow fusion and
plasmid transfer leading to expression of luciferase. Lysis of the cell mixture is analyzed for
luminescence. (A) Wild-type (B) W243S (▲) and W243S + WT (●). (C) G237R (▲) and G237R
+ WT (●). (D) G365C (▲) and G365C + WT (●). The transition pH obtained from 3 independent
experiments are shown in the top right corner of each graph. Error bars are standard deviations.
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Figure 2.10. Quantitative luciferase-based fusion assay induced by ligand (FlAsH). CHO
effector cells are expressing HA and carrying plasmid with red firefly luciferase gene under the
control of T7 polymerase are overlaid on target cells. BHK-21 target cells express the T7
polymerase. After FlAsH buffer induction the reaction is neutralized, and sufficient time is allowed
for fusion, transfer of luciferase plasmid, and expression of luciferase protein. The bioluminescence of the lysates are analyzed using Bio-Tek Synergy 2 plate reader. Graph shows
luminescence normalized to effector cells expressing wild-type HA. Modular system (●), effector
cells expressing both HA4xCys and HAcmyc, show luminescence comparable to wild-type for
[FlAsH] ≥ 2.5 µM. Effector cells expressing only HA4.4 (▲) showed no luciferase activity. Dose
response with variable slope was fitted to data of three independent experiments with the error
bars as the standard deviation produced a EC50 = 1.28 µM.
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Figure 2.11. Application of modular systems. Diagram depicts a modular system co-expressing
a sensing HA and fusion active HA. The sensing trimer would be triggered by a stimulus specific
to the target cell. Refolding of the sensing HA along with the autocatalytic activation of the fusion
trimer would facilitate the delivery of a cargo to the target cell.
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𝑴𝑭𝑰𝒔𝒂𝒎𝒑𝒍𝒆 − 𝑴𝑭𝑰𝒃𝒌𝒈𝒅
𝑵𝑴𝑭𝑰 =
𝑴𝑭𝑰𝒎𝒂𝒙 − 𝑴𝑭𝑰𝒃𝒌𝒈𝒅
Figure 2.12. Normalized median fluorescence intensity (NMFI). Non-transfected CHO cells
(negative) were stained to determine the median fluorescence intensity background (MFIbkgd).
Cells transfected with only HAcmyc and stained are used to determine the median fluorescence
intensity maximum (MFImax).
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𝑹𝑳𝑼𝒔𝒂𝒎𝒑𝒍𝒆 − 𝑹𝑳𝑼𝒃𝒌𝒈𝒅
𝑵𝑹𝑳𝑼 =
𝑹𝑳𝑼𝒎𝒂𝒙 − 𝑹𝑳𝑼𝒃𝒌𝒈𝒅
Figure 2.13. Normalized relative luminescence unit (NRLU). Non-transfected CHO cells were
incubated with target cells and treated in the same way to determine the relative luminescence unit
background (RLUbkgd). CHO cells transfected with HA wild type were used to determine the
maximum relative luminescence unit (RLUmax).
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𝑻𝒐𝒑 − 𝑩𝒐𝒕𝒕𝒐𝒎
𝒀 = 𝑩𝒐𝒕𝒕𝒐𝒎 +
(𝟏 + 𝟏𝟎𝒍𝒐𝒈(𝑬𝑪𝟓𝟎−𝒙)∗𝒔𝒍𝒐𝒑𝒆 )
Figure 2.14. Dose response with variable slope. Four variables were fitted to the raw data. The
top and bottom being the maximum and base response relatively. A variable slope is fitted to the
transition area. The amount of agonist required to get half of the maximum response, EC50, is
used to characterize the sample.
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CHAPTER 3
MEMBRANE ENVIRONMENT
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Abstract

The membrane’s role in autocatalytic activation of HA can lend insight into the mechanism
of fusion through viral fusion proteins. The suggested interaction of HA fusion peptide with the
membrane shows the N-terminal portion of the peptide to embed in the nonpolar membrane core
and disrupt lipid structure (Han, et al., 2001; Huang, et.al., 2004; Li et al., 2005; Vaccaro, et al.,
2005). The cleavage of the fusion peptide was also shown to have eliminated autocatalytic
activation (Lee et al., 2006). Excess amounts of fusion peptide in solution can disrupt the
membrane (Vaccaro, et al., 2005) and lead to effects in our immunostaining assay or FlAsH kinetic
assay. Here, we present evidence that incubation of CHO cells expressing HA with exogenous
fusion peptide causes the conformational change in wild type and mutants. We also present a
cholesterol dependence on the kinetics of activation as well as the extent of fusion.

Background

The structures of hemagglutinin in its pre- and post- fusion conformation has been solved
for many subtypes and give insight to the key conformational changes that occur during fusion. In
the pre-fusion state the HA exists as a trimer on the surface of the viral envelope with the Nterminus containing the fusion peptide and the C-terminus containing the transmembrane domain
inserted in the virion. Each monomer contains a A-helix – β-loop – B-helix region that it referred
to as the coiled-coil (Wilson et al., 1981; Figure 3.1). The trimer comes together to form a cavity
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where the fusion peptide resides before the conformational change (Chen et al., 1999). After
acidification the HA1 headgroups dissociate and the major structural changes happen in HA2
subunit. The β-loop in the coiled-coil becomes a α-helix which combines A-helix and B-helix
forming a large α-helical rod near the N-terminal which contains the fusion peptide (Qiao et al.,
1998; White et al., 2008; White et al., 2016; Harrison et al., 2015). This loop to helix transition
extends the fusion peptide toward the target membrane. Another key structural change is a portion
of the B-helix becomes a loop which connects the large α-helical rod to a shorter α-helix. This
transition allows for the C-terminal region to fold against the N-terminal region which bring the
fusion peptide and transmembrane domain in close proximity forming a six-helix bundle (6HB).
This post-fusion structure shows how the N-terminal fusion peptide potentially inserts into the
target membrane and after folding which facilitates fusion ends up in the same membrane as the
C-terminal transmembrane domain.
The composition of the membrane has also been shown to affect fusion mediated by
enveloped viruses. Cholesterol, which modulates the membrane environment, can change the
fluidity, thickness, and intrinsic curvature. The polar hydroxyl group which aligns with ester
carbonyl group of phospholipids creates an ordering effect that reduces the movement of the lipid
tails (Heftberger et al., 2015). The order also straightens out the lipid tails causing a thicker
membrane (Pan et al., 2008). Cholesterol also causes an intrinsic negative curve is generated due
to the small polar head group compared to its apolar region. These highly curved areas created by
the intrinsic negative curve have been linked to fusion intermediates (Chernomordik et al., 2008;
Aeffner et al., 2012). The preference of cholesterol for longer saturated phospholipids generate
lipid rafts (Feigenson et al., 2006; Lingwood et al., 2010). These lipid rafts have been suggested
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to transport viral fusion proteins to locations on the cell for infection as well as viral budding
(Manes et al., 2003; Scheiffele et al., 1999; Freed, 2015; Yang et al., 2016).

Methods and Materials

Cell Culture.
CHO-K1 cells (ATCC CCL-61) were cultured in Dulbecco’s Modified Eagles Medium:
Kaighn’s Modification of Ham’s F-12 (DMEM:F-12K). Medium was supplemented with 10%
fetal bovine serum (FBS) (Hyclone, Logan, UT), 100 µg/ml penicillin and 100 µg/ml streptomycin
(Life Technologies, Grand Island, NY) to generate full growth medium. CHO-K1 cells were
cultured at 37 ˚C and 5% CO2. BHK-21 cells were cultured as described in chapter two and used
as target cells in fusion assays.

Plasmids and Transfections.
The retroviral expression vector pLNCX2 (Clontech, Mountain View, CA) was used with
the fowl plague virus (A/FPV/Rostock/34) HA gene (Lin et al. 2001) ligated in-between a XhoI
and NotI site. Overlap extension PCR was used to replace the second half of the fusion peptide
region, residues 11-20, with a c-myc epitope tag (EQKLISEEDL), herein referred to as HAcmyc.
This allowed for specific staining with anti-c-myc antibody for the activated conformation.
Overlap extension PCR was used to replace fusion peptide residues 13-18 (amino acids 355-360)
with a tetra-cysteine tag (CCPGCC) and ligated into pLNCX2 (Clontech), herein referred to as
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HA4xCys. All DNA manipulations were performed in E. Coli DH5α and cultured in Luria broth
and supplemented with ampicillin at 50 µg/mL unless otherwise stated. Transfection using
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) of CHO-K1 cells were used in all
experiments to surface display HA libraries following the manufacturer’s recommended
procedure. Transfected CHO cells were cultured in selective full growth medium, 0.85 mg/ml
geneticin (Hyclone, Logan, UT), 16 h post-transfection and selected for 48 h before any assay.
After first 48 h selection 0.25 mg/ml geneticin was used to grow cells and maintains ~100%
expression for 1 week.

Membrane Manipulation.
Transfected CHO-K1 cells were grown to ~90% confluency in T-25 flasks (Corning,
Corning, NY) before used in any experiments. Adherent cells were detached from flasks using
0.05% trypsin-EDTA (Hyclone) and transferred into 1.5 mL microcentrifuge tubes and placed on
ice. The cells were washed twice with PBSA and pelleted using a benchtop microcentrifuge. The
cells were then subjected to either a cyclodextrin treatment or FPV fusion peptide treatment. To
remove cholesterol from the membrane cells were exposed to methyl-β-cyclodextrin (SigmaAldrich, St Louis, MO) at indicated concentration in serum free DMEM:F-12K media for 15 min
at room temperature. A synthetic peptide purchased from Genscript that is made up of the first 20
amino acids of HA2 from fowl plague virus HA, herein referred to as FPV-FP (Genscript,
Piscataway, NJ), was applied to the cells. The quantity of peptide order was 14 mg at a purity of
95% aliquoted into 5 vials which was diluted in dH20 to 1 mM for our freeze stocks. Trifluoroacetic
acid which is used to cleave synthesized peptides from solid resins was removed and guaranteed
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to be < 1 % in all aliquots. Cells were incubated in serum free DMEM:F-12K media buffered with
15 mM HEPES with peptide at indicated concentrations for 30 min at 37˚C. After incubation with
cyclodextrin or FPV-FP cells were pelleted at 800xg and resuspended and washed twice with
PBSA.
After washes cells that were treated with methyl-β-cyclodextrin (MβC) were aliquoted into
tubes at ~ 5 x 105 cells. These cells were pelleted in a microcentrifuge and resuspended in FlAsH
buffer, containing 2.5 µM FlAsH-EDT2 and 0.25 µM EDT in serum free 1:1 DMEM:F-12K
medium. Negative FlAsH buffer contains no FlAsH-EDT2 and 0.25 µM EDT in serum free 1:1
DMEM:F-12K media. Cells resuspended in FlAsH buffer were immediately analyzed by flow
cytometry to monitor FlAsH binding kinetics.
After washes cells that were treated with FPV-FP were immunofluorescently stained and
assayed by flow cytometry. Cell surface expression was determined by monoclonal antibody
(mAb) HC2 and HA conformation was determined by pre-activation specific monoclonal antibody
HC58 (Sugrue et. al, 1990). For HAcmyc-expressing cells, activated state was monitored by mAb
9e10 (Lee et al 2006).

Peptide Incubation Followed by pH Pulse.
To determine the effect of low concentrations of FPV-FP a triplicate set of peptide
experiments were followed by a low pH incubation. After FPV-FP incubation at a low
concentration, 1 µM, and 3 extensive wash steps cells were exposed to a pH induction step, citrate
buffer at pH range from 5.0 to 6.0 for 5 min at room temperature. Cell surface expression was
determined by monoclonal antibody (mAb) HC2 and HA conformation was determined by pre54

activation specific monoclonal antibody HC58 (Sugrue et. al, 1990). Bi-modal response allowed
for the flow cytometry data to be gated based on controls to allow the calculation of fraction of
cells induced. The fraction induced represents the number of cells positive for activated HA
divided by the number of cells analyzed and expressing HA. A variable slope dose-response curve
was fitted to data in order to calculate an EC50 value that characterized the transition pH.

Fusion Assay.
The same fusion assay from Chapter 2 using a luciferase reporter (Byrd-Leotis et. al.) to
assess HA-mediated membrane fusion was applied after MβC incubations. Plasmid containing
Red Firefly Luciferase gene (Pierce) was cloned into a pLNCX2 plasmid (Clontech). Primers
were designed to add the luciferase gene in between a XhoI and Not I site with a T7 polymerase
promoter upstream of the gene. CHO cells were transfected with HA plasmid or co-transfected
with two distinct HA genes and a plasmid containing Red Firefly Luciferase gene (Pierce) under
the control of a T7 bacteriophage promoter using Lipofectamine 2000 (Invitrogen) according to
manufactures protocol to create effector cells. 16 h post-transfection, the effector cells were placed
in selective growth medium containing 0.85 mg/ml geneticin (Hyclone) for 48 h. Target BHK-21
cells were transfected with pCAG-T7, a plasmid containing T7 bacteriophage polymerase also
using Lipofectamine 2000. pCAG-T7 pol was a gift from Ian Wickersham (Addgene plasmid #
59926). 48 - 72 h after transfection of the target cells, the HA-expressing cells were washed with
PBS and treated with 0.05% trypsin-EDTA (Hyclone). The CHO effector cells were then overlaid
on the target cells and incubated for 1 h at 37 ˚C to allow cells to adhere. Cells were washed once
with PBS (Hyclone) and then exposed to appropriate induction buffer for 5 or 15 min. At the end
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of the induction complete growth medium was added to neutralize the reaction. The cells were
incubated for 6 h at 37 ˚C to allow for cell-cell fusion and plasmid transfer leading to expression
of luciferase. The cells were then washed once with PBS and lysed with 0.1 ml of lysis buffer
(Pierce) and incubated in a 37 ˚C shaker for 15 min. 20 µl of lysate was transferred to a 96-well
plate and 50 µl of D-luciferin substrate and 1 µl of Firefly signal enhancer (Pierce) were added to
each well. Luciferase-catalyzed luminescence resulting from cell fusion was quantified using a
Bio-Tek Synergy 2 multi-mode plate reader (Bio-Tek, Winooski, VT).

Results

MβC Effect on FlAsH Binding Kinetics.
To test the importance of the cell membrane MβC was used remove cholesterol from the
membrane. Cells that were transfected with HA4xCys plasmid were used in FlAsH binding kinetic
experiments. Cells expressing HA4xCys were incubated in 10 mM MβC for 15 min at room
temperature then resuspended in FlAsH buffer and analyzed via flow cytometry. HA4xCys cells
that were treated with MβC (blue) show a delay in FlAsH binding that is not seen in HA4xCys
cells with no MβC (black) incubation (Figure 3.2). HA4xCys cells that had no MβC incubation
(negative control) showed that FlAsH binding occurred at ~ 420 sec. FlAsH binding was delayed
an average of 155 sec over three independent experiments when treated with MβC. This indicates
that by reducing the amount of cholesterol in the membrane there is a longer lag time before the
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ligand binding that indicates the conformational change. This would indicate that the membrane
environment plays a role in the refolding of HA.

Extent of Fusion Reduced by MβC.
We further tested the role cholesterol plays in the fusion catalyzed by HA. We showed
previously that the conformational change of HA is delayed with the depletion of cholesterol. The
quantitative luciferase fusion assay was used in combination with MβC incubation to determine
the effect of cholesterol depletion on the extent of fusion. CHO cells expressing wild type HA
were tested using either a 5.2 pH induction or a FlAsH induction. The modular system expressing
both a fusion active HA, wild type HA, and a sensing HA, HA4.4, was also tested with the same
two induction steps. Prior to inducing the conformational change, the cells expressing the HA’s
were incubated with non- MβC, 5 mM MβC, 10 mM MβC, or 20 mM MβC buffer for 15 min at
room temperature. Following the neutralizing of the MβC buffer the cells were overlaid with target
cells, BHK-21 expressing T7 polymerase, and induced by a 5 min pH 5.2 or a 15 min FlAsH buffer
incubation. The cells were then treated as explained in the methods and the extent of cell fusion,
between HA expressing CHO and target BHK-21 cells, was quantified using a Bio-Tek Synergy
2 multi-mode plate reader. The raw data was normalized using positive and negative controls as
described in Figure 2.12. CHO cells expressing only wild type HA produced luciferase signal when
induced by low pH but had no luciferase signal when induced with FlAsH ligand. The titration of
MβC shows a decrease in the extent of fusion as higher levels of cholesterol is depleted (Figure
3.3). The modular system had a positive luciferase signal for both the low pH and FlAsH ligand
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induction steps. Similar to the HA wild type the modular system’s extent of fusion was decreased
as the amount of cholesterol depleted increased (Figure 3.3).
Taken together, with the longer lag time before activation, the cholesterol in the membrane
plays a role in the activation and fusion catalyzed by HA. The link of HA to lipid rafts can
potentially contribute to the both the delay in kinetics and the reduction in fusion.

FPV-FP Effect on HA Activation.
To test the role of the membranes interaction with HA we used fusion peptide in solution
which mimics the exposed fusion peptide of HA after activation and allows for the interaction of
the peptide with a membrane. The fusion peptide of fowl plague virus (A/FPV/Rostock/34) HA is
derived from the first 20 amino acids from the N-terminal of HA2 subunit. The sequence of the
peptide is GLFGAIAGFIENGWEGLVDG and was synthesized and purified as described in the
methods section. Our goal was to mimic an activated HA environment when the fusion peptide is
exposed and able to interact with the cell membrane. Fusion peptides have been shown to bury
into the target membrane in a kinked α-helical structure and disrupt the lipid packing (Huang,
et.al., 2004; Li et al., 2005; Vaccaro, et al., 2005). Cells that were transfected with HA wild type
plasmid and gone through selection were used to monitor refolding after incubation with FPV-FP
at different concentrations. After the incubation with FPV-FP cells expressing HA wild type were
immunofluorescently stained and analyzed via flow cytometry. Using mAb HC58, which is
conformation specific to pre-activation state, we observed that median fluorescence intensity for
3 independent experiments dropped when using concentrations of peptide ≥ 10 µM (Figure 3.4).
As a negative control a myosin light chain kinase (MLCK) peptide, with a sequence of
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ARRKWQKGGHAVRAIGRLSS, was used and no concentration of this peptide showed a
decrease in fluorescence. The drop in median fluorescence indicates that the HA have gone through
the conformational change to the active state. This suggests that the peptide disrupting the
membrane packing is sufficient enough to cause the conformational change.
Similarly, CHO cells transfected with HAcmyc, which allows us to monitor the active state
of HA, were also used in FPV-FP experiments. Using mAb 9e10 to monitor the active state of HA
after incubations with FPV-FP, we observed that concentrations of peptide ≥ 100 µM showed an
increase in median fluorescence while the negative control MLCK showed no increase (Figure
3.5). The increase in fluorescence over three independent experiments indicates that the HAcmyc
was going through its conformational change to the active state induced only by the peptide. This
agreed with the peptide induction seen in the wild type HA monitored by an antibody specific to
pre-activation state. The need for a higher amount of peptide induction seen in HAcmyc can be
attributed to the mutant HA lacking a complete fusion peptide region. HAcmyc mutant has the
second half of the fusion peptide region mutated. Plasticity reports of the fusion peptide region
have shown a number of mutations that effect the interaction with the membrane (Li et al., 2005;
Vaccaro et al., 2005; Qiao et al., 1999). A single mutation of Gly-1 to Serine allows for lipid
mixing (hemifusion) but inhibits fusion and molecular simulations suggests that the peptide
interacts with the lipids differently. Whereas, mutation of Gly-1 to Valine blocks both hemifusion
and fusion. HAcmyc trimers have eight total mutations with three hydrophobic residues being
replaced by charged ones. It’s possible that the fusion peptide interacts with the membrane but not
as effectively as the wild-type. Due to the coarse-grained titration it is possible that 10 µM FPVFP might be close to the amount of peptide needed to cause the conformational change in the
59

mutant HA’s. The concentration difference needed to activate HA wild type and mutant HA might
be closer than the data suggests. To determine if other HA mutants also required higher
concentrations of peptide to induce conformational change HA4xCys was tested as well as
HAcmyc using mAb HC58.
CHO cells expressing HA wild type, HAcmyc, and HA4xCys were all incubated with FPVFP and immune-stained using mAb HC58 to monitor the conformational change. Both mutant
HA’s, HAcmyc and HA4xCys, required higher concentrations of peptide to induce conformational
change when compared to HA wild type (Figure 3.6). The median fluorescence decrease is cause
by a loss of HC58 binding, which is indicates the HA has gone through a conformational change.
Wild type HA (black) is induced at ≥ 10 µM FPV-FP were as the two mutants, HAcmyc (blue)
and HA4xCys (green), are induced at 100 µM FPV-FP. This agrees with the mAb 9E10 stain that
also shows that HA’s with mutated fusion peptide region require higher concentrations of peptide
to induce conformational change.

Low Concentration of FPV-FP Followed by pH Pulse.
To further test the ability of FPV-FP to disrupt the membrane environment and its effect
of HA we used a low concentration of peptide followed by a pH pulse. CHO cells expressing HA
wild type were first incubated in FPV-FP before being exposed to a low pH pulse. We used 1 µM
FPV-FP because at this concentration the peptide was not able to induce the conformational
change. A MLCK peptide was used as a negative control. Following the peptide incubation, a pH
titration ranging from 5.0 – 6.0 was applied to determine the pH of transition. Staining with mAb
HC58 was used to monitor the pre-activation state and analyzed via flow cytometry. Histogram
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curves from flow cytometry were used to determine the percentage of cells that had gone through
the conformational change. The percent induced was the population of cells that loss the ability to
bind mAb HC58. The pH of transition, pH at which 50% of the cells had been induced, for FPV
HA wild type has been shown to be at pH 5.4. The pH titration showed that with the incubation of
1 µM FPV-FP (●) before the pH pulse destabilized the HA and the transition pH increased to 5.78
when fitting a dose response variable slope curve (Figure 3.7). The negative control MLCK peptide
(▲) showed no effect on the transition pH when compared to the wild type which was calculated
to be 5.36 after fitting a dose response curve to the data. These results agree with the previous
peptide induction and also indicates that the FPV-FP destabilizes the membrane allowing for the
HA to transition at higher pH’s.

Discussion

The need to better understand the fascinating phenomenon of autocatalysis seen in the
conformational switch of HA can lead to better engineering the modular systems shown in Chapter
2. It could also broaden the understanding of the conformational change necessary for enveloped
viral infection. The model of cell-wide communication proposed in Chapter 2 and its dependence
on the fusion peptide was the rationale for the experiments done in this chapter. It is speculated
that the hydrophobic fusion peptide’s initial exposure, displacement from the cavity, and ability to
insert into its own membrane resulting in locally altered membrane properties and providing a
decrease in activation energy to enable refolding. This model for autocatalysis suggests that the
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interaction of HA with the membrane plays a key role in the cell-wide switching behavior which
we tested with exogenous peptide and depletion of membrane cholesterol.
Membrane composition was altered by applying methyl-β-cyclodextrin (MβC) to cells to
extract cholesterol (Lu, et al., 2012). The cells with depleted amounts of cholesterol showed longer
lag time when monitoring the conformational change with HA4xCys mutant. The link of not only
HA but various other viral fusion proteins to lipid rafts supports the idea that by disrupting that
association and the lateral dissociation of HA results in slower kinetics and decreased fusion
activity (Krautkramer et al., 2014; Molotkovsky et al., 2018; Dou et al., 2018; Ohkura et al., 2014;
Chang et al., 2012; Takeda et al., 2003). The lipid rafts are cholesterol dependent and cyclodextrin
treatment has been shown to deplete percentages of the membrane that exists as rafts. The cells
treated with MβC also showed a lower extent of fusion. Cells with lower amount of cholesterol
showed a reduction in fusion by about 50%. This leads to questions weather other viral fusion
proteins have a cholesterol dependence. The key role that the membrane environment has on viral
fusion can impact therapy of many enveloped viruses.
Exogenous fusion peptide from H7 fowl plague virus was used to alter the local membrane
environment and it was shown to cause the conformational refolding of HA at a neutral pH of both
wild type HA and mutant HA’s (HAcmyc and HA4xCys). It was also shown that using lower
concentrations of exogenous peptide causes the transition pH of wild type HA to increase which
indicates that the fusion peptide destabilizes trimers expressed on the surface of the cell. The
suggested interaction of HA fusion peptide with the membrane shows the N-terminal portion of
the peptide to embed in the nonpolar membrane core and disrupt lipid structure (Han, et al., 2001;
Huang, et.al., 2004; Li et al., 2005; Vaccaro, et al., 2005). The cleavage of the fusion peptide was
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also shown to have eliminated autocatalytic activation (Lee, 2007). Excess amounts of fusion
peptide in solution disrupt the membrane (Vaccaro, et al., 2005) and lead to refolding of HA
trimers. Studies with other membrane altering peptides, such as β-amyloid pathogenic factor in
Alzheimer’s which causes pores, has been shown to inhibit Influenza A virus (White, et al., 2014).
These experiments taken together with the cholesterol depletion experiments suggest that the
membrane environment plays a role in the activation of HA and in the fusion catalyzed by the viral
protein.

63

Appendix

Figure 3.1. Structural rearrangements of HA2. The trimer structures of HA2 fusion subunit are
shown here in the pre-fusion (A) and post-fusion (B) state. Yellow triangle indicates where the
transmembrane domain would be located. Only the HA2 subunit is shown. The coiled-coil is
represented by the A-helix (blue), β-loop (green), and the B-Helix (cyan). The key regions that
have conformational changes are the β-loop (green) and helix section of the B-Helix (purple). The
fusion peptide (red) is only depicted in the pre-fusion state and is on the N-terminus side of the Ahelix (blue). The structures were downloaded from the Protein Data Bank. 2HMG (A) and 1QU1
(B) and rendered on UCSF Chimera not drawn to scale.
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Figure 3.2. Cholesterol depletion causing delayed kinetics. CHO cells were transfected with
HA4xCys. Cells expressing HA4xCys were incubated for 15 min at room temperature in 10 mM
MβC (blue) or non- MβC buffer (black). The cells treated with MβC showed a longer lag time that
is no seen in the negative control. The delay is attributed to the depletion of cholesterol and its role
in autocatalysis.
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Figure 3.3. Extent of fusion with cholesterol depletion. CHO cells expressing wild type HA
and a modular system (HA wild type and HA4.4) were tested for extent of fusion after a MβC
incubation. Non- MβC, 5 mM MβC, 10 mM MβC, and 20 mM MβC (shown from left to right
grey-scale bars) was used prior to the indicated induction step. Both systems were tested using
either a pH 5.2 or a FlAsH ligand induction. Average of 3 independent were normalized and std
deviations shown as error bars.
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Figure 3.4. FPV-FP wild-type activation. CHO cells expressing wild type HA were incubated
with peptide at indicated concentration. FPV-FP (black) or MLCK (grey) peptide was incubated
with the cells for 30 min at 37˚C. The cells were stained with, pre-active state specific antibody,
mAb HC58. The median fluorescence intensity was averaged for 3 independent experiments
with the std deviation shown as error bars.
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Figure 3.5. FPV-FP HAcmyc activation. CHO cells expressing HAcmyc were incubated with
peptide at indicated concentration. FPV-FP (black) or MLCK (grey) peptide was incubated with
the cells for 30 min at 37˚C. No significant fluorescence above the negative control (nontransfected cells) was observed for incubations with the MLCK peptide. The cells were stained
with, active state specific antibody, mAb 9E10. The median fluorescence intensity was averaged
for 3 independent experiments with the std deviation shown as error bars.
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Figure 3.6. FPV-FP induction. CHO cells expressing wild type HA (black), HAcmyc (blue),
and HA4xCys (green) were incubated with peptide at indicated concentration. FPV-FP peptide
was incubated with the cells for 30 min at 37˚C. The cells were stained with, pre-active state
specific antibody, mAb HC58. The median fluorescence intensity was averaged for 3
independent experiments with the std deviation shown as error bars.
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Figure 3.7. Low concentration FPV-FP followed by pH pulse. CHO cells expressing wild
type HA were incubated with either FPV-FP or MLCK peptide at 1 µM. FPV-FP (●) or MLCK
(▲) peptide was with the cells for 30 min at 37˚C. After the peptide was removed the cells were
treated at indicated pH. The cells were stained with, pre-active state specific antibody, mAb
HC58. The median fluorescence of a non-transfected CHO cell was used to determine a gate
separating active and pre-active states. After subtracting background, the percent induced was
determined. The data was averaged for 3 independent experiments with the std deviation shown
as error bars.
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CHAPTER 4
AUTOCATALYTIC ACTIVATION OF X31 AND CROSSTALK
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Abstract

The conformational change of foul plague virus HA expressed on CHO cells were shown
to have switching behavior and in Chapter 2 we demonstrate crosstalk between HA mutants of the
same subtype (Lee et al., 2006). The proposed model of refolding of FPV HA to the fusion active
conformation could potentially be applied to other viral fusion proteins or subtypes of HA. Here
we are using the robust cell surface display system as a tool to demonstrate that the autocatalytic
phenomena apply to other subtypes of HA and other viral fusion proteins. Here, we present
evidence for the ability to activate other viral fusion proteins or other subtypes of HA via
autocatalytic activation. Communication between different subtypes and other viral fusion proteins
was monitored using a similar immunoassaying via flow cytometry.

Background

In this chapter we will discuss a human influenza virus hemagglutinin (X31-HA) as well
as two other viral fusion proteins from vesicular stomatitis virus (VSV-G) and human
immunodeficiency virus type 1 (gp-160). All three viral fusion proteins are found on the viral
envelope and mediate fusion with the target membrane. They share a common pathway through
fusion with similar intermediates. The two subtypes of HA, H3 and H7, differ in sequence but the
overall structure is very similar. X31-HA is still made up of a receptor binding domain, HA1, and
a fusion domain, HA2, that is proteolytically cleaved. The HA1 subunit’s of H7 and H3 share a
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sequence identity of 39.3% while the HA2 subunits share a 68.6% similarity (Russel et al., 2004).
The overall conformational change and process of fusion remains the same between the subtypes.
The viral fusion proteins from different viruses differ not only in sequence but the
structures are diverse (Figure 4.8). Even with the difference in sequence the three proteins studied
here share common themes. In each case the protein exits as a trimer on the viral membrane before
it is triggered to undergo its conformational change that forms an extended trimer intermediate,
which brings the fusion peptide region toward the target membrane (Harrison, 2015; Baquero et
al., 2015). The pre- and post-fusion structures indicate that the extended intermediate folds on
itself bringing the two membranes into close contact, presumably initiating lipid-mixing, much
like what is shown for H7 HA in Figure 3.1 forming 6-helix bundles (Roche et al., 2006; Roche et
al., 2007; Gallo et al., 2003; Moore et al., 2003).
Vesicular stomatitis virus viral fusion protein (VSV-G) exists as trimers on the surface of
the viral membrane but has also been observed to exists as a monomer in some cases (Roche et al.,
2006; Albertini et al., 2012). The viral fusion protein is made up of a combination of α-helices and
β-sheets which differs from hemagglutinin which is mainly helices. In its prefusion state the VSVG fusion peptide loops are completely exposed unlike both HA and gp-120/gp-41 complex and are
found between 3 β-sheets. Each monomer contains two fusion loops that are extended toward the
target membrane after acidification. VSV-G is triggered into its conformational change in the
early endosome at pH ~ 6.1 and requires no other proteins to drive fusion (Kim et al., 2017; Roche
et al., 2008; Stanifer et al., 2011). The reversibility of VSV-G is unique to this viral fusion protein
compared to HA. The viral fusion protein exists in a dynamic equilibrium that HA does not exits
in until the pH has already dropped. HA’s metastable state does not allow for any partially
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activated trimers unless there is a pH drop. The pH change in VSV-G shifts the equilibrium of the
proteins conformational state. Ultimately the final fusion state after the extended intermediate folds
back is also a 6-helix bundle that brings the two apposing membranes in close proximity (Roche
et al., 2007).
Human immunodeficiency virus type 1 viral fusion protein (gp-160) is proteolytically
cleaved to a trimer consisting of three gp-120/gp-41 heterodimers where it exists in its metastable
state much like hemagglutinin. The triggering is mediated by gp-120 receptor binding domain that
is shed after binding CD4, but the full activation of viral fusion protein requires a second
coreceptor, CXC4R OR CCR5 of the chemokine family of receptors, (Moore et al., 1990; Harrison,
2015; Gallo et al., 2003; White et al., 2008). The binding of the coreceptor has been shown to
enhance the refolding and is some cases seen to be required for complete activation (Mkrtchyan et
al., 2005; Platt et al., 2007). The fusion peptide of gp-41 is found on the N-terminus of the fusion
subunit similar to HA. After the triggering the fusion peptide is extended toward the target
membrane and the final post fusion states also resembles the 6-helix bundle.

Methods and Materials

Plasmids.
Fowl plague virus (A/FPV/Rostock/34) HA gene (Lin et al. 2001) was digested with XhoI
and NotI and ligated into the retroviral expression vector pLNCX2 (Clontech, Mountain View,
CA). A previously created HA mutant with a c-myc epitope tag sequence (EQKLISEEDL) cloned
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into the fusion peptide residues 11-20 (amino acids 353 – 362) was also ligated into the pLNCX2
(Clontech) vector (Lee et al. 2006), herein referred to as HAcymc. In a similar cloning step human
influenza virus (A/Aichi/68/X31) HA, H3 subtype, was mutated with c-myc epitope tag sequence
into the fusion peptide region at residues 11 – 20. The c-myc epitope tagged H3 HA was digested
and ligated into pLNCX2 (Clontech), herein referred to as X31-HAcmyc. Oligonucleotides were
designed to isolate the fusion protein, protein G, from vesicular stomatitis virus (VSV) from
pVSV-G plasmid (Clontech). The resulting PCR product was digested with Xho-I and Not-I and
ligated into pLNCX2 (Clontech), herein referred to as VSV-G. The mammalian expression
plasmid containing gp-160, p96ZM651gp160-opt, was obtained from the NIH Aids Reagent
Program. The gp-160 gene is inserted into a pcDNA3.1(-) plasmid with a CMV promotor and
geneticin resistance. All DNA manipulation were performed in E. coli Top10 or DH5α and
cultured in Luria broth (LB; 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) supplemented with
ampicillin at 50 µg/ml.

Cell Culture.
CHO-K1 cells (ATCC CCL-61) were cultured in Dulbecco’s Modified Eagles Medium:
Kaighn’s Modification of Ham’s F-12 (DMEM:F-12K). The medium was supplemented with 10%
fetal bovine serum (FBS) (Hyclone, Logan, UT), 100 µg/ml penicillin and 100 µg/ml streptomycin
(Life Technologies, Grand Island, NY). CHO-K1 cells were transfected with plasmids using
Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA) according to manufacturer’s protocol.
Transfected CHO cells were cultured in selective growth medium, 0.85 mg/ml geneticin (Hyclone,
Logan, UT), 16 h post-transfection and selected for 48 h before any assay. After first 48 h selection
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0.25 mg/ml geneticin was used to grow cells and maintains ~100% expression for 1 week. All
transfections of CHO cells followed the same selection process unless stated otherwise. CHO-K1
cells were used to surface express HA wild type, HA mutants, HA X31, gp-160 and VSV-G in all
assays, except where indicated otherwise. Co-transfections were done at a 1:1 plasmid ratio
keeping the total amount of plasmid used in transfections according to the manufactures protocol.

Analysis of Induced HA.
Cells are transfected and selected in a T-25. After selection cells are grown in t-25 flasks
to ~ 90% confluency. All adherent cells were detached using 0.05% trypsin-EDTA (Hyclone) and
aliquoted into 1.5mL microcentrifuge tubes and placed on ice. Cells were washed twice with
PBSA and pelleted at 800xg using a benchtop microcentrifuge. The cells were then exposed to a
pH induction step, citrate buffer at appropriate pH for 5 min at room temperature or a FlAsH
induction step by addition of FlAsH buffer, containing 2.5 µM FlAsH-EDT2 and 0.25 µM EDT
in serum free 1:1 DMEM:F-12K media, for 15 min at room temperature. Negative FlAsH buffer
contains no FlAsH-EDT2 and 0.25 µM EDT in serum free 1:1 DMEM:F-12K media. The TCFlAsH in cell tetra-cysteine tag detection kit (Molecular Probes # T34561, Eugene, OR) was used
and optimized according manufacture’s recommendations. After induction step the cells were
immunofluorescently stained and assayed by flow cytometry.

Cell surface expression was

determined by monoclonal antibody (mAb) HC2 and HA conformation was determined by preactivation specific monoclonal antibody HC58 (Sugrue et. al, 1990). A previously shown mutant,
HAcmyc, was used to monitor activated state by mAb 9e10 (Lee et al 2006). Bi-modal response
allowed for the flow cytometry data to be gated based on controls to allow the calculation of
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fraction of cells induced. A variable slope dose-response curve was fitted to data to calculate an
EC50 value which characterized the transition pH.

Results

Bi-modal Transition of X31 HA.
The fusion peptide region is used as a detection flag due to the irreversibility of the
conformational change and the fact that this region is exposed only in the activated state. CHO
cells transfected and selected with the epitope tagged H3 subtype, X31-HAcmyc, were used to
analyze the pH at which the protein goes through its conformational change via flow cytometry.
After selection cells were exposed to a 5 min low pH pulse then immunofluorescently stained with
mAb 9E10 to detect exposure of c-myc epitope tag. Flow cytometry data from a pH titration shows
that the transition/activation pH at which 50% of the cells have gone through the conformational
change is at pH 5.23 (Figure 4.1). Negative control, CHO cells that were not transfected, were
used to determine a background fluorescence, and set gates to determine which population of cells
were positive for c-myc. The number of cells that were positive for c-myc, activated HA on the
surface, was divided by the number of cells expressing HA in order to calculate the fraction
induced which was plotted against pH (Figure 4.1). A variable slope dose response curve was
fitted to the data and the EC50 (the pH at which half the max response is observed), was used to
characterize the transition/activation pH. The cells exposed to the pH pulses demonstrated a
bimodal response at the cell population level. The samples that were exposed to pH in the transition
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region, immunofluorescently stained, and analyzed via flow cytometry show two-state response
(Figure 4.2). At a high pH 5.6 very few cells are activated and at a low pH 5.0 very few remain
inactive. The intermediate states (pH 5.2 and pH 5.4) the activation is bimodal and included no
cells with an intermediate level of c-myc exposure. These intermediate pH’s had two distinct
populations which indicates a mixture of cells that are fully in the pre-active state and another
population that is fully in the active state. Flow cytometry data suggests that no cell has a fraction
of it HA induced so there is no cell that have both pre-active and active state HA on the surface.
This switch behavior of all or nothing, also seen in H7 subtype HA of influenza virus, indicates
that each individual cell reaches a threshold at which it completely commits all the HA on the
surface to refold to the active state.

Subtype Crosstalk: H3 HA and H7 HA.
The ability to crosstalk between the two subtypes of HA, H7 and H3, was assessed by coexpressing both proteins. CHO cells were transfected at a 1:1 plasmid ratio with both HA4xCys,
which is the tetra-cysteine construct in the FPV H7 HA, and X31-HAcmyc. With the transition pH
characterizing the two HA subtypes only being 0.2 pH units in difference we decided to use a nonacidic induction step. X31-HAcmyc showed a small amount of c-myc signal at pH 5.4 so the use
of an acidic induction might result in false positives. In our co-expression model the HA4xCys is
used as the sensing HA which will be induced by a ligand, FlAsH, while the X31-HAcmyc will be
used as the reporter HA that will give a positive signal using the c-myc epitope flag for the active
state. This model is similar to the previous experiments with crosstalk in the H7 subtype between
different mutants. If the autocatalysis phenomenon applies to the H3 subtype, then ligand-induced
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H7 HA should cause all HA on the surface of a cell to activate including the X31-HAcmyc HA.
After transfection a selection for expressing CHO cells was applied in the same fashion as the
other transfections. The cells were then incubated for 15 min in FlAsH buffer, neutralized, and
resuspended in PBSA. The cells were immunofluorescently stained and analyzed via flow
cytometry. The negative control, transfected cells incubated in negative FlAsH buffer, show no cmyc positive cells for both co-expressing and X31-HAcmyc samples (Figure 4.3). Cells incubated
with the FlAsH buffer have a positive c-myc signal only for the co-expressing samples, while the
cells expressing only X31-HAcmyc are negative for c-myc signal (Figure 4.3). The cells
expressing only X31-HAcmyc and the co-expressing system were also pulsed at pH 5.0 to
demonstrate the capability of activating all HA on surface directly (Figure 4.3). The flow
cytometry data indicates that the phenomena of autocatalysis applies across subtypes. Cells
expressing only the X31 HAcmyc, which has no tetra-cysteine tag, did not respond to the ligand.
The co-expression system allows for a sensing HA, HA4xCys, to be activated by FlAsH and in
turn activate X31 HAcmyc via autocatalysis. Crosstalk allows for the indirect activation of H3 HA
subtype by a ligand. The ability to induce X31 HA indirectly with a ligand that only binds FPV
HA could suggests the subtypes share a common self-activating mechanism.

Fusion Protein Crosstalk: VSV-G and H7 HA.
The autocatalytic phenomenon applying across different subtypes of HA supports our
hypothesis for the role that the membrane plays in activation. If the disruption of the membrane
environment can alter other subtypes we want to test if other viral fusion proteins that go through
a similar conformational change. Vesicular stomatitis virus (VSV) has a viral fusion protein (G)
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that undergoes a conformational change at pH ~ 6.1 (Kim et al., 2017; Libersou et al., 2010; Roche
et al., 2008; Stanifer et al., 2011). This pH is significantly higher than the pH of transition for H7
HA (pH 5.4) and could be used in a co-expression model similar to the system with two subtypes.
Cells co-expressing VSV-G (viral fusion protein of VSV) and HAcmyc can potentially indicate
crosstalk between different viral fusion proteins in a modular system. The VSV-G protein would
work as a pH sensor that would respond at pH’s below 6.1 and HAcmyc would be a reporter
protein that would give a positive c-myc signal if crosstalk observed. A pH titration would show
a positive c-myc signal arising from the indirect induction of HAcmyc from VSV-G at a pH
significantly higher than the transition pH. CHO cells were co-expressed with both VSV-G (which
activate at 6.1) and HAcmyc (which should not activate until 5.4) plasmids and selected. The cells
were induced at high pH (7.0), intermediate pH (5.8), and a low pH (5.2). After the induction step
the cells where immunofluorescently stained and analyzed via flow cytometry. The flow cytometry
data shows that at all pH inductions and even with no induction step we always had a positive cmyc signal (Figure 4.4). The induction at pH 5.2 has a lower mean fluorescence due to the loss of
the second peak which are cells that have a higher expression level of HA (Figure 4.4). The second
peak is believed to be lost due to the low pH being more stressful on the cells lysing some during
the induction and subsequent spin cycles. There was no sample of cells that resembled our negative
controls (non-transfected CHO cells). The VSV-G protein differs from HA due to the viral fusion
protein conformational change to catalyze fusion is reversible (Kim et al., 2017; Stanifer et al.,
2011; Albertini et al., 2012; Roche et al., 2002). The pH shifts the equilibrium of the proteins on
the cell surface being either in its active or pre-active state. With some VSV-G proteins always
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switching from one state to the other we believe that this is the cause for the HA on the surface of
the cell to also go through its conformational change.

Fusion Protein Crosstalk: gp-160 and H7 HA.
In order to further test if the autocatalysis applies to other viral fusion proteins we tested
gp-160 of human immunodeficiency virus type 1 (HIV-1). This viral fusion protein shares
similarities to HA including being synthesized as a single polypeptide, gp-160, which is
proteolytically cleaved into a mature gp-120/gp-41 complex (Checkley et al., 2012; Krell et al.,
2004; Blumenthal et al., 2012). The complex exists on the surface of the virus as a heterotrimer
with gp-120 being the receptor binding domain and gp-41 being the transmembrane fusion active
domain carrying the fusion peptide region (Checkley et al., 2012; Krell et al., 2004; Blumenthal et
al., 2012). The receptor binding domain, gp-120, goes through an irreversible conformational
change induced by the binding of CD4. The conformational change of the receptor binding domain
leads to the gp-120/gp-41 complex coming apart as gp-120 is shed from the surface and gp-41, the
fusion active domain, remaining tethered to the surface via its transmembrane domain (Moore et
al., 1990). The shedding of gp-120 induced by receptor binding allows us to use mAb α-gp-120
(this reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID,
NIH: Anti-HIV-1 gp120 Monoclonal (F105) from Dr. Marshall Posner and Dr. Lisa Cavacini) in
immunostaining to monitor for the conformational refolding reagent. (Posner et al., 1993). CHO
cells were transfected with gp-160 plasmid and selected using geneticin, like in previous
experiments. The cells were then induced by a CD4 (obtained through the NIH AIDS Reagent
Program, Division of AIDS, NIAID, NIH: Human Soluble CD4 Recombinant Protein (sCD4) from
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Progenics) incubation for 2 h at 37˚C. A titration of CD4 concentrations, ranging from 0 – 1000
µM, was used to determine the amount of CD4 required to cause the refolding and shedding of gp120. After the CD4 incubation the cells were extensively washed to remove any gp-120 left in
solution. The cells were then labeled with α-gp-120 and appropriate secondary anti-body before
being analyzed via flow cytometry. Flow cytometry data indicates that 100 and 1000 µM CD4
generates the largest response of gp-120 shedding (Figure 4.5). The decrease in α-gp-120 binding
indicates that gp-160 has refolded. The response to refolding is not bimodal like the conformational
change seen in HA. A mock incubation with buffer containing no CD4 was is shown as our
maximum fluorescence. Concentrations 100 and 1000 µM CD4 overlap and a maximum shedding
of CD4 response was observed.
CHO cells transfected with gp-160 plasmid were used to test the stability of the protein at
a pH that would induce HA. Cells were induced at pH 5.0 for 5 min at room temperature then
stained with both α-gp-120 and α-c-myc. The fusion protein of HIV, gp-160, is stable at low pH’s
and shows no evidence of gp-120 shedding linked to the conformational change at pH 5.0 which
would activate HA (Figure 4.6D). Cells that were incubated in a mock induction with 0 µM CD4
in serum free medium (Figure 4.6A) show a similar stain to cells incubated at pH 5.0 (Figure 4.6D).
This indicates that low pH does not cause the conformational change seen when incubated with
soluble CD4. Shedding of the receptor domain is seen only when incubating the cells with soluble
CD4 at 10 µM and 100 µM (Figure 4.6B & 4.6C). Cells incubated with 100 µM CD4 showed the
maximum amount of CD4 shedding with 24.3% of the cells analyzed still positive for mAb α-gp120. None of the cells expressing only gp-160 had any significant α-c-myc stain (Figure 4.6).
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Co-expressing the HA reporter protein, HAcmyc, with gp-160 allows us to test modular
systems by inducing with either low pH or with CD4 incubation. With anti-bodies, α-gp-120 and
α-c-myc, that are conformational specific for the two fusion proteins the modular systems
expressing both gp-160 and HAcmyc were tested for crosstalk. CHO cells were co-transfected
with the two fusion proteins and selected using geneticin. The plasmid containing gp-160 has the
same promotor and geneticin resistance as the pLNCX2 plasmid used with all of our HA
transfections. The cells expressing the modular system were then induced with either 0 µM (Figure
4.7A) or 100 µM (Figure 4.7B) CD4 at 37˚C for 2 h or a room temperature 5 min incubation at
indicated pH. The range of pH’s tested, pH 5.4 – 5.0 (Figure 4.7 C-D), correspond to the transition
range of HA. The expression levels of both HAcmyc and gp-160 were not as high as we normally
see following selection. Both proteins appear to have an expression level ~ 65% when probing
with mAb gp-120 and HC2. The modular system, similar to cells expressing only gp-160, shows
shedding of the receptor domain gp-120 after incubation with CD4 which indicates a refolding of
the HIV fusion protein. This refolding does not show any significant c-myc stain meaning that the
HA on the surface of the cell is still in its inactive state. The refolding of gp-160 does not cause
any change in the conformational state of HA. However, when induced by low pH the activated
HAcmyc does show the ability to cause gp-120 shedding seen by the decrease in α-gp-120 stain
(Figure 4.7 C-D). In the transition pH’s, 5.4 and 5.2, the cells become positive for α-c-myc stain
and negative for α-gp-120 stain (Figure 4.7 C & D). At 5.0 pH, which was seen in Figure 4.6 not
to reduce gp-120 staining, all of the cells are negative for gp-120 probe. This indicates that HA
activation is sufficient enough to crosstalk, presumably through the membrane, and cause refolding
of gp-160 seen by the decrease in gp-120 stain.
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Discussion

The crosstalk of different subtypes of HA and between different enveloped viral fusion
proteins was tested in this chapter. Taking advantage of the communication between H7 HA
mutants, we examined the ability to activate other viral fusion proteins (VSV-G and gp-160) and
other subtypes of HA via the same pathway. Activating fusion proteins from other enveloped
viruses would suggest that these proteins can communicate through modulations of the local
membrane properties. The need to better understand autocatalysis would facilitate our modular
systems that can benefit more efficient therapy and delivery to target cells.
We first tested the ability to communicate through autocatalysis with other subtypes of HA.
Human influenza virus (A/Aichi/68/X31) HA was first exposed to a pH titration pulse to determine
the pH of transition. The transition pH was demonstrated to be at pH 5.2, which is 0.2 pH units
lower than the H7 FPV-HA. The transition of activation has the same bimodal response as the
FPV-HA. Flow cytometry data showed that no cell exists in a state in which only a fraction of its
HA trimers have undergone the irreversible conformational change. Indicating that H7 and H3
subtypes share the autocatalytic response where the cell reaches a critical point and all HA trimers
on the cell are committed to refolding.
Sharing a common bimodal response to activation allowed us to test modular systems
where different subtypes of HA could be co-expressed similar to the systems shown in Chapter 2.
In this chapter we continued with the H7 sensing mutant, HA4xCys, triggered by ligand binding
to induce the conformational change co-expressed with a signal HA H3 X31-HAcmyc. The
bimodal response of X31-HA leads us to expect the modular system to work if the communication
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results solely from modulation of local membrane properties. Similar to previous modular systems
the different subtype system also gave a positive signal which indicates a shared autocatalytic
mechanism for activation.
The fusion protein of vesicular stomatitis virus (VSV-G) goes through a conformational
refolding induced by pH 6.1 but unlike all other enveloped viral fusion proteins it is reversible
(Kim et al., 2016; Libersou et al., 2010; Roche et al., 2008). The higher pH of activation was tested
in our modular system with the VSV-G acting as the sensing protein that would then communicate
with HAcmyc (reporter trimer). All of our pH pulses, ranging from 7.2 – 5.2, indicated that the
HAcmyc had refolded even in the absence of any pulse. Negative controls, CHO cells transfected
with only HAcmyc, showed no refolding. The equilibrium of the state of VSV-G is shifted
depending on the pH. At high pH’s there are still some G protein that might be undergoing the
refolding. The reversibility of VSV-G suggests that the refolding of these proteins is enough to
cause the HA to refold via modulations in the membrane. There is a possibility that the refolding
caused by co-expression of these two proteins might arise from protein-protein interactions. At
this point we only have the membrane being a common link as to one possible reason for crosstalk.
We continued to test other viral fusion proteins that are not reversible and share a similar
conformational change to HA. The fusion protein of HIV (gp-160) is proteolytically processed to
generate two subunits, gp-120 (receptor binding) and gp-41 (contains N-terminal fusion peptide),
which then are induced into a conformational change to catalyze fusion via CD4 binding (Falcigno
et al., 2004; Welman et al., 2007; Eckert and Kim, 2001). We assessed that gp-120/gp-41 complex
does not demonstrate autocatalytic activation when induced by purified soluble CD4 via
conformational sensitive antibodies. Co-expression of gp-160 and HA was used to determine the
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ability to trigger gp-160 activation by pH pulse and HA activation by CD4 binding. This indicates
that different membrane fusion proteins can communicate during activation through modulation
of local membrane properties. Modular systems expressing both gp-120 and HA show the ability
to crosstalk only when using the pH induction. CD4 induction did not show any crosstalk and this
might be due to the gp-160 not causing enough of a disturbance in the cell membrane. Complete
viral fusion protein rearrangement of gp-120/gp-41 complex has been linked to a co-receptor that
might be needed in this case. The CD4 binding might only cause shedding of gp-120 but the
complete extended trimer discussed in the background section could require another binding event.
Future experiments of expression levels might help conclude if enough gp-160 is going through
the conformational change to elicit a change in HA. The crosstalk between the two fusion proteins,
observed only after low pH induction, might be due to HA causing a more substantial disruption
in the lipid membrane. Expression levels for of both proteins when co-expressed were ~ 65% even
after selection. This suggests that there might be a density dependence for complete activation.
These studies elucidate similarities of fusion mechanisms among different classes of fusion
proteins and subtypes of influenza HA. The triggering caused by communication of different viral
fusion proteins suggests a common mechanism mediated through the membrane.
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Appendix

Figure 4.1. pH induction of X31 HA. CHO cells expressing X31-HAcmyc were induced at
indicated pH. The cells were stained with mAb 9E10 which is specific for the activated state.
The fraction induced are the number of cells that are positive for c-myc (active HA) divided by
number of cells expressing HA. An average of 3 independent experiments with the standard
deviation as error bars is shown.
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Figure 4.2. Bi-modal activation of X31 HA. CHO cells expressing X31-HAcmyc were induced
at pH 5.6 (A), pH 5.4 (B), pH 5.2 (C), and pH 5.0 (D). The cells were stained with mAb 9E10
which is specific for the activated state. The fraction induced were cells that observed a higher cmyc stain than the negative control as described in the chapter. The gate shows the fraction that
is in the refolded active state. The activation of X31 HA is bimodal, which is covered in the
results section, similar to that of FPV HA.
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Figure 4.3. H3 and H7 HA crosstalk. CHO cells expressing X31-HAcmyc (row A) and coexpressing X31-HAcmyc and HA4xCys were induced as indicated in the top right corner of each
graph. Column 1 induced at pH 7.0 with no FlAsH, column 2 induced at pH 7.0 with FlAsH
buffer, and column 3 induced at pH 5.0 with no FlAsH. The cells were stained with mAb 9E10
(blue curve) which is specific for the activated state of the X31-HAcmyc. Non-transfected CHO
cells (black curve) were also subject to the same treatment and used as negative controls. Insert
in column 2 shows the FlAsH binding (green).
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Figure 4.4. HA and VSV-G crosstalk. CHO cells were co-transfected with HAcmyc (reporter
trimer) and VSV-G (sensing trimer) plasmids. After selection cells were induced as indicated in
the top right corner of each graph (pH 7.0, pH 5.8, or pH 5.2). The equilibrium of the reversible
conformational change of VSV-G protein shifts to the active state below pH 6.1. The cells were
stained with mAb 9E10 (blue curve) which is specific for the active state of the HAcmyc. Nontransfected CHO cells (black curve) were used as negative control.
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Figure 4.5. CD-4 induction of gp-160. CHO cells were transfected with gp-160 plasmid and
selected with geneticin. The cells were incubated for 2 h at 37˚C with 0 µM CD4 (blue), 10 µM
CD4 (red), 100 µM CD4 (green), and 1000 µM CD4 (not shown because it overlaps with 100
µM). Non-transfected CHO cells (black) were used as negative control. After CD4 incubation
the cells were stain with anti-gp-120. The reduced stain of gp-120 correlates with the
conformational change of gp-120/gp-41 complex due to CD4 binding.
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Figure 4.6. Dual stain of gp-160. CHO cells were transfected with gp-160 plasmid and selected
with geneticin. The cells were incubated for 2 h at 37˚C with 0 µM CD4 (A), 10 µM CD4 (B),
100 µM CD4 (C), or 5 min room temperature at pH 5.0 (D). Non-transfected CHO cells were
used as negative control to set the gates. After incubation the cells were stain with α-gp-120 and
α-c-myc. The reduced stain of gp-120 correlates with the conformational change of gp-120/gp-41
complex due to CD4 binding and shedding gp-120 domain. In all sample no significant
population was positive for c-myc stain.
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Figure 4.7. HA and gp-160 crosstalk. CHO cells were co-transfected with both gp-160 and
HAcmyc plasmid and selected with geneticin. The cells were incubated for 2 h at 37˚C with 0
µM CD4 (A), 100 µM CD4 (B) or 5 min room temperature at pH 5.4 (C), pH 5.2 (D), and pH
5.0 (E). Non-transfected CHO cells were used as negative control to set the gates. After the
induction incubations the cells were stain with α-gp-120 and α-c-myc. The reduced stain of gp120 correlates with the conformational change of gp-120/gp-41 complex due to CD4 binding and
shedding gp-120 domain. The populations positive for c-myc stain indicate HA that has gone
through the refolding to its active state.

93

Figure 4.8. Structural comparison of viral fusion proteins. All images were generated using
UCSF Chimera and structures downloaded from PDB. Orange section indicates the fusion
peptide/loop section and red arrows indicate the direction of the transmembrane region embedded
into viral membrane. (A) VSV-G (PDB 2J6J) has a .32% sequence identity with the HA1 subunit
of HA shown in (B). (C) Fusion domain, gp41, of gp160 has a 18.92% sequence identity with the
fusion domain of HA shown in (B).
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CHAPTER 5
HA LANDSCAPE
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Abstract

To engineer the HA protein for novel properties it is essential to understand the structurefunction relationship. Directed evolution allows us to create large libraries of HA mutants with
altered phenotypes due to sequence mutations. Mutations are introduced by random genetic
mutagenesis. These large libraries also allow us to gather information on the sequence-function
relationship which is often hard to predict. Using the reporter HA, HAcmyc, we can screen for
mutants with desired phenotypes, such mutant that are positive for expression and the ability to
undergo the conformational change after a pH pulse. Directed evolution was used in the lab
previously to study key residues that control pH activation. We used random mutagenesis and
screening combined with next generation sequencing (NGS; Mi-Seq Ilumina high-throughput
sequencing) to comprehensively assess amino acid sites that can tolerate mutations without
compromising correct folding or the ability to be activated (Figure 5.1). This allowed us to map
out potential sites for mutagenesis of desired phenotypes. Landscapes of potential mutation sites
for several antibodies or antibody fragments have been produced as well as other proteins
(Traxlmayr et. al., 2012; Doolan et. al., 2015; Roscoe et. al., 2013; Wrenbeck et al., 2017;
Rosenfeld et al., 2016; Whitehead et al., 2012), enabling efficient design of combinatorial
libraries for engineering new protein functions.
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Methods and Materials

Cell Culture.
CHO-K1 cells (ATCC CCL-61) were cultured in Dulbecco’s Modified Eagles Medium:
Kaighn’s Modification of Ham’s F-12 (DMEM:F-12K). Medium was supplemented with 10%
fetal bovine serum (FBS) (Hyclone, Logan, UT), 100 µg/ml penicillin and 100 µg/ml streptomycin
(Life Technologies, Grand Island, NY) to generate full growth medium. CHO-K1 cells were
cultured at 37 ˚C and 5% CO2.

Plasmids and Transfections.
The retroviral expression vector pLNCX2 (Clontech, Mountain View, CA) was used with
the fowl plague virus (A/FPV/Rostock/34) HA gene (Lin et al. 2001) ligated in-between a XhoI
and NotI site. Overlap extension PCR was used to replace the second half of the fusion peptide
region, residues 11-20, with a c-myc epitope tag (EQKLISEEDL), herein referred to as HAcmyc.
This allowed for specific staining with anti-c-myc antibody for the activated conformation. All
DNA manipulations were performed in E. Coli DH5α and cultured in Luria broth and
supplemented with ampicillin at 50 µg/mL unless otherwise stated. Transfection using
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) of CHO-K1 cells were used in all
experiments to surface display HA libraries following the manufacturer’s recommended
procedure. Transfected CHO cells were cultured in selective full growth medium, 0.85 mg/ml
geneticin (Hyclone, Logan, UT), 16 h post-transfection and selected for 48 h before any assay.
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After first 48 h selection 0.25 mg/ml geneticin was used to grow cells and maintains ~100%
expression for 1 week.

DNA Library Construction and Expression.
A library was generated using random error-prone PCR using nucleoside analogs dPTP
and 8-oxo-dGTP to induce single point mutants (Zaccolo et al., 1993; Zaccolo et al., 1993). The
error-prone PCR was ran for 10 cycles with the analogs at 2 µM concentration in order to create a
library with single point mutations (Colby et al., 2004). PCR products were ran on an agarose gel
then purified via electro-elution, digested with XhoI and NotI, and ligated into retroviral
expression vector pLNCX2 (Clontech). Library size was determined by serial dilution plating onto
ampicillin agar plates. CHO cells were transfected with the library and selected with geneticin as
described above.

Analysis of pH-induced Libraries and Recovery of Plasmids.
After selection of CHO cells transfected with library cells were subjected to a pH activation
step. Adherent cells were detached using 0.05% trypsin-EDTA (Hyclone) and aliquoted into
Eppendorf tubes and placed on ice. Cells were washed twice with PBSA and pelleted in between
washes at 800xg. Citrate buffer at pH 5.0 was then used to activate CHO cells expressing the
library of mutants for 5 min at room temperature. After activation step cells were
immunofluorescently stained with monoclonal antibody (mAb) HC2 for expression and anti-cmyc for active state conformation. Cell sorting was done with FACS Aria II to isolate double

98

negative, single positive, and double positive populations as described in Figure 5.1. Quick-DNA
universal kit (Zymo, Irvine, CA) was used on the sorted cells to recover the DNA plasmids.

Sequencing and Analysis of Mutations.
The recovered plasmids were PCR amplified with primers specific to the pLNCX2 vector
and used for high-throughput sequencing. Ilumina Mi-Seq with NextEra XT DNA library
preparation kit was used to evaluate the starting and sorted libraries. The St. Petersburg genome
assembler (SPAdes) pipeline read error correction tool, BayesHammer, was used to remove
potential errors and rare k-mers (Bankevich et al., 2012). Analysis of sequencing data was done
on CLC genomics workbench.

Results

Library Creation and Expression.
Error-prone PCR was applied to generate the library of mutants. The HAcmyc plasmid was
mutated, which is used as a detection flag for activation, using nucleoside analogs dPTP and 8oxo-dGTP and ligated back into the pLNCX2 retroviral plasmid (Clontech). Highly competent
cells were transformed, grown, and maxi prepped to recover plasmids. The size of the library was
calculated to be > 106 mutants via serial dilution plating onto ampicillin plates. CHO cells were
transfected with the library and selected as described in the methods. The mutated HAcmyc library
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allowed for the screening of both expression and activation simultaneously. A plasmid recovery
kit (Zymo) was used to harvest plasmids from cells.

Screening for Expression and Activation.
After the selection of CHO cells transfected with the HAcmyc mutant library, the cells
were incubated in a pH 5.2 pulse for 5 min. We have shown that wild type FPV HA shows
activation at pH 5.2 for 5 min so this pulse should activate any HA mutants that retain the ability
to be activated similar to the wild type. After the pulse cells were immunofluorescently doublestained with mAb HC2, which screens for expression, and mAb 9E10, which screens for the
activated state. Flow cytometry data of the library shows distinct populations that are double
negative for both antibodies, positive for only HC2, and double positive for both HC2 and 9E10
(Figure 5.2). Gates were drawn based on negative and positive controls. Non-transfected CHO
cells, that did not go through any selection, were used as the negative control. CHO cells that were
transfected with un-mutated HAcmyc plasmid was used as a positive control. This double stain
allowed for us to sort the three separated populations. Immediately after the sort a plasmid recovery
kit (Zymo) was used to harvest plasmids from the cells to keep a physical link between genotype
and phenotype.

Isolation of Sorted Populations.
The plasmids were recovered from the three sorted cell populations: double negative, HC2
single positive, and double positive. These plasmids were used as the template for PCR
amplification in the following sequencing steps. Due to the transient transfection there was a
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possibility of a cell taken up more than one plasmid and expressing multiple mutant trimers or
even a mixed trimer where the trimer is made up of different monomer mutants. If this were the
case, then we can potentially get false positives in each population due to an average effect from
multiple mutants rather than screen for individual mutants. To test our sorting efficiency, we PCR
amplified using the harvested plasmids as our templates, digested, and ligated back into pLNCX2.
These plasmids were then used to transfect and select CHO cells expressing the sorted library
populations. The cells were treated and induced using the same protocol from before the sort. The
three cell samples were induced with pH 5.2 for 5 min and double stained with mAb HC2 and
mAb 9E10 and analyzed via flow cytometry. The flow cytometry data shows that each population
has ≥ 82.6 % of the cells in the quadrant in which it was selected for using the same negative and
positive controls to determine the gates (Figure 5.3). The double negative cells have 82.6 %, the
single HC2 positive cells have 96.0 %, and the double positive cells have 84.0% of the cells within
the quadrant that it was sorted for (Figure 5.3). Mutants that do not resemble what they were
screened for, double negative cells having a 17.4% population in the single positive quadrant, may
arise from cells that take up more than one mutant with different phenotypes.

Sequencing and Analysis.
The harvested plasmids from the sorted cells were then used as the template in a PCR
amplification for the MiSeq sequencing using NextEra XT DNA library preparation kit. The three
sorted libraries along with the original library were prepared according to the manufactures
protocol and sequenced. The raw data from the sequencing results were first filtered through
BayesHammer read error correction tool to remove potential errors. After the initial error filtering,
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only high-quality reads with a Phred quality score ≥ 35 were kept corresponding to a probability
of 3.0 x 10-4 of an incorrect base call. The stringent quality control was enforced in order to rule
out sequencing errors which in the analysis could be considered mutations from the original
library. After filtering each sample (single positive, double positive, and original library) produced
≥ 106 high quality reads that were used for the analysis.
The sequencing analysis was done with CLC genomics workbench (Qiagen, Hilden,
Germany). The reads from all four samples were treated in the same manner. The reads, which had
an average length of 204 bp after the quality trim, were aligned to the reference HAcmyc sequence
to create larger contigs. A minimum of half of the total read length had to match the reference
sequence and a similarity fraction of 0.8 between the aligned region and reference was
implemented. Non-specific reads, where a read aligns at more than one position with an equal
score, were ignored in the final mapping. A low frequency variant caller was used to determine
the amount of times a base call differed from the reference gene. The filtering out of low quality
reads allows for more relaxed parameters in the variant calling algorithm. Only positions with a
coverage ≥ 100 were considered. Coverage is the amount of reads that line up to the reference at
that particular position. The reading frame of the HAcmyc sequence was used to determine the
variants that caused mutations in the amino acid sequence. Variants that caused silent mutations,
deletions, or frame shifts were filtered out.
The variant caller output the mutations at each position and at what frequency they
appeared. The frequency of the original library was used to compare and determine the change in
mutational rate seen after the selection for expression (HC2) and after the double selection for both
expression and activation (HC2 and c-myc). The frequency of the mutation after the expression
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selection ,fHC2, was divided by the frequency of mutation of the original library, fLib, for each
mutation and summed up for every position. A summation of all the frequency ratios was
determined for each position to evaluate the change in mutational rate after the selection. The
change in mutational rate for each amino acid position is shown in Figure 5.4 after the expression
(HC2) selection. Change in mutation rates (fHC2 / fLib) that drop below 1 represent amino acid
positions that did not tolerate mutations. Low mutation rate ration indicates that the frequency at
which a mutation appears in the library is significantly larger than the frequency that it appears in
the selected cells. After the expression selection we observed a few positions where the frequency
ratio was below 0.25. This indicates that point mutants don’t disrupt the expression of HA and
were only observed in the first position, last position, and the presumed binding site of the HC2
antibody (Figure 5.4, indicated in red). A heat map of the mutational rate data was rendered onto
the known sequence of H7 hemagglutinin (Protein Data Base ID: 1TI8) and positions within the
loop region of HA1 head group shown in red can potentially be involved in mAb HCs binding
(Figure 5.5). Positions G142, T144, S145, C147, R148, and R149 all have a change in mutational
rate frequency ratio lower than .01 which strongly indicates that these residues have a role in HC2
binding (Figure 5.3). The actual binding site the antibody has not been defined but the point
mutation, G144E, has been shown to disrupt the binding of HC2 (Sugrue et. al., 1990). The lack
of mutations tolerated at the binding site of antibodies used in the selection work as an internal
control.
The library was simultaneously screened for both expression and activation (using mAb
HC2 and mAb c-myc) and analyzed in the same way. The frequencies of the mutation found in the
original library were used to compare to the frequencies found after the double selection. The
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frequency of the mutation after the double selection, fcmyc, was divided by the frequency of
mutation of the original library, fLib, for each mutation and summed up for every position. The
change in mutational rate (fcmyc / fLib) was again defined as the ratio of the sum of single mutations
at every position and graphed against the amino acid position (Figure 5.6). The residues in the
mAb HC2 binding site again were selected against and shown in red. The mAb c-myc epitope site,
which we cloned into the positions 353 – 362, also had a change in mutation rate below .01 for
every position indicating the lack of mutations tolerable at that residue. The average mutational
change rate was significantly observed when comparing the two selections and could be seen in
the heat map of the double selection rendering (Figure 5.7). The heat map indicates a more
significant selection when compared to just the single HC2 selection due to the protein having
more intolerable mutation residues. This data gives us sites that do not tolerate mutations when
trying to keep both expression and the ability to activate. The majority of the mutation intolerable
positions have residues which are titratable.
One region with low mutational tolerance is the second alpha helix in the coiled coil and
the β-loop which previously has been shown by our lab to effect fusion capability and the stability
of fusion activation. Residues E406, D409, E411, E416, E417, S429, and D445 are all found in
the β-loop or the following larger α-helix and all have a change in mutational rate below .25 (Figure
5.7, residues shown in red). Further down that same α-helix we find another region of low
mutational tolerance, which is the fusion peptide and the surrounding residues that are potentially
in the fusion peptide pocket (Figure 5.8). Focusing on the fusion peptide region we observe
mutational conserved residues (N17, L323, D451, D454, and N458) which all are within 5 Å of
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one or multiple fusion peptide residues. Possible interactions with the fusion peptide might hinder
the ability for the HA to undergo its conformational change.

Discussion

The phenotypic characteristics of the conformational change plays an important role in
host infection. Studying the residues that contribute to the stability of HA allow for a better
understanding of what mutations in nature can cause potential pandemics. Previous work of
residues contributing to the stability of HA has focused on subtypes H3 and more recently H5
(Daniels et at., 1985; Steinhauer et al., 1996; Thoennes et al., 2008; Cross et al., 2001; BrydLeotis et al., 2015; Reed et al., 2010; Reed et al., 2009). We used error-prone PCR to introduce
mutations in an unbiased way to the entire gene. Our assay to monitor conformational change
isn’t constrained by having to retain fusion so it allows us to explore mutations that wouldn’t
appear in fusion assays. The CHO cells were transfected with the library of mutants and induced
at pH 5.2.
Expression selection identified positions G142, T144, S145, C147, R148, and R149 all
have a change in mutational rate frequency ratio lower than .01 which strongly indicates that
these residues have a role in HC2 binding (Figure 5.3). The actual binding site the antibody has
not been defined but the point mutation, G144E, has been shown to disrupt the binding of HC2
(Sugrue et. al., 1990). Previous studies have shown the ability mapping binding interfaces using
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directed evolution and deep sequencing (Whitehead et al., 2012; Fowler et al., 2010; Araya et al.,
2011)
The double selection for expression as well as activation identified regions of interest that
did not tolerate the mutations found in the original library. The positions that did not tolerate
mutations also identified mutants that were more stable than the wild-type which would have
been induced at that pH. The B-helix, β-loop, and fusion peptide pocket were identified as
having residues that play a role in the stability of HA. The β-loop residues that did not tolerate
mutations are Glu406, Asp409, Glu411, and Glu414. None of these residues have previously
been identified as key contributors to the conformational change. In the B-helix we identify
Glu416, Lys417, Ser429, Glu445, and Thr449 as being positions that did not tolerate mutations.
Previous studies have identified residues in the B-helix of HA2 that stabilize HA. Mutation
Ser429Pro in sub-type H7 has been identified by previous graduate students in the lab to stabilize
HA which agrees with our sequencing data. Another position is in the B-helix that has been
identified is Glu105 (numbering based on HA2 subunit of H5 subtype) which resembles the
positioning of our Glu445. The mutation Glu105Lys has been found to stabilize HA which
would agree with our results (Reed et al., 2009).
In the fusion pocket we identify the largest cluster of mutational intolerant positions.
There has been literature that suggests the stability of HA is influenced by the residues in the
fusion peptide and fusion peptide pocket (Cross et al., 2001; Ilushina et al., 2007; Thoennes et
al., 2008; White et al., 2006). We identify Gly343, Gly346, and Gly350 in the fusion peptide as
being positions that don’t tolerate mutations. These Glycine residues have been identified as
crucial residues contributing to the interaction with the target membrane (Li et al., 2005). Our
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data indicates that Glycine residues stabilize the peptide in the fusion pocket. Mutations at these
positions can potentially disrupt the spacing needed for the other residues in the pocket to create
proper contact with the cavity. In the fusion peptide pocket, which is a cavity where the peptide
forms extensive contacts in the pre-active state, we identify Asn17, Asp451, Asp454, Asn458,
and Leu323 as residues that did not tolerate the mutations found in the original library. Position
Asp112 (numbering based on HA2 subunit of H5 subtype) has been shown to destabilize HA
when mutated to Lys and resembles our Asp454 position (Byrd-Leotis et al., 2015; Reed et al.,
2010). This aspartic acid is highly conserved among all HA sub-types and has been shown to
form several H-bonds with residues in the fusion peptide. The Asp to Lys mutation did not
appear in our original mutation library. Another mutation that was been found to destabilize HA
is Asn114Lys. This Asn114 resembles Asn458 that we identified in our sequencing data. The
destabilization discrepancies might arise from sequence differences between H5 and H7 or from
different assays used (refolding versus fusion) to determine the pH of transition.
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Appendix

Figure 5.1. Identification of mutation tolerant sites. A mutant clone library was generated and
ligated into retroviral plasmids. After selection for transformants, cells were sorted into three
groups by FACS based on expression and activation. Clones negative for both expression and
activation (blue), clones positive for expression but not activation (red), and clones positive for
both expression and activation (green). Plasmids from the three populations will be recovered
and sequenced along with the presort library to identify all mutations at all HA positions.
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Figure 5.2. Pre-sort library. CHO cells were transfected with the mutant library and selected
with geneticin. The cells were induced by pH 5.2 for 5 min and double stained with mAb HC2
and mAb 9E10 and analyzed via flow cytometry. Non-transfected CHO cells (negative) and
CHO cells transfected with HAcmyc (positive) were used to determine the gates. The cells were
sorted by quadrants: double negative (blue), single HC2 positive (red), and double positive
(green).
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Figure 5.3. Post-sort isolated populations. CHO cells were transfected with plasmids recovered
from the sorted cells. The cells were induced by pH 5.2 for 5 min and doubled stained with mAb
HC2 and mAb 9E10 and analyzed via flow cytometry. Non-transfected CHO cells (negative) and
CHO cells transfected with HAcmyc (positive) were used to determine the gates. Double
negative stain (A-blue), double positive stain (B-green), single positive HC2 (C-red), and an
overlay of the three populations (D) are shown.
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Figure 5.4. Change in mutation rate after HC2 selection. The change in mutational rate
(described in the chapter) was plotted against the amino acid position for the sequencing data
recovered from the expression selection (HC2). Positions that were highly intolerable to mutations
are shown in red and are believed to be implicated in HC2 binding. The green line represents
mutation rate change of 1.
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Figure 5.5. Heat map of mutation rate after HC2 selection. The mutational rate change attribute
from the expression selection was rendered onto the H7 HA structure (1TI8) that was downloaded
from the Protein Data Bank. The figure was prepared using Chimera. The potential residues
implicated in binding HC2 are shown in red.
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Figure 5.6. Change in mutation rate after double selection. The change in mutational rate
(described in the chapter) was plotted against the amino acid position for the sequencing data
recovered from the double selection (HC2 and c-myc). Positions that were highly intolerable to
mutations are shown in red and blue and are believed to be implicated in HC2 and c-myc binding
respectively. The green line represents mutation rate change of 1.
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Figure 5.7. Heat map of mutation rate after double selection. The mutational rate change
attribute from the double selection was rendered onto the H7 HA structure (1TI8) that was
downloaded from the Protein Data Bank. The figure was prepared using Chimera.
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Figure 5.8. Heat map of mutation rate in fusion peptide vicinity. The mutational rate change
attribute from the double selection was rendered onto the H7 HA structure (1TI8) that was
downloaded from the Protein Data Bank. The figure was prepared using Chimera. This image
shows the residues that did not tolerate mutations that are within 5 angstroms of the fusion peptide.
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CHAPTER 6
SUMMARY AND RECOMMENDATIONS
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Summary

The ability for viral fusion proteins to catalyze fusion with the target cell facilitates the
delivery of the viral contents for infection. The ability for these proteins to undergo a
conformational change in response to a stimulus allows them to drive fusion. Hemagglutinin (HA)
refolds to an active state induced by a low pH. The refolding exposes a fusion peptide region that
likely inserts into the target membrane leading to disruption of the lipid packing and eventually
fusion. The need to understand the mechanism of refolding that leads to fusion would benefit future
engineering of fusogenic machines responding to specific environments. An understanding of the
mechanism of fusion, which has shared similarities among all enveloped viruses, could lead to
potential therapies targeting novel contributors of the process.
The results indicate a novel alternative pathway of activation for influenza hemagglutinin
through binding the fusion peptide region which we presume destabilizes it in the pre-activation
pocket. Ligand induction of enveloped viral fusion proteins, such as HA, with small molecules
that have high affinity for the fusion peptide region can benefit future therapies. Furthermore,
trimers activated by ligand can activate non-ligand binding trimers through autocatalysis. Taken
advantage of the autocatalysis found in the activation of HA we can create modular systems where
sensing HA can refold due to a novel stimulus which would in turn trigger an HA with an actuating
component. Controlling the conformational change which leads to fusion allows for future
application varying from biosensing, molecular imaging, or drug delivery. Our modular systems
activated by ligand showed not only the ability to refold non-ligand bind trimers but also drive
fusion when the actuating trimer retains that phenotype.
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The mechanism of autocatalysis was further characterized in Chapter 3. The kinetics of
refolding as well as the role of the membrane environment were tested to better understand the
phenomenon of autocatalysis. Previous work had proposed a model of autocatalysis that
potentially arose from effects mediated by locally altered membrane structure and tension (Lee et.
al., 2006). The cell-wide communication of HA’s suggested the protein’s interaction with the
membrane to be a key contributor. Using methyl-β-cyclodextrin (MβC) to extract cholesterol we
showed that these cells had slower kinetics and a lower extent of fusion overall when compared to
cells not treated with anything. The dependence of HA and possibly other viral fusion proteins on
cholesterol for more efficient fusion could impact future therapies. Exogenous fusion peptide,
which has been shown to embed into and disrupt lipid packing, was used to determine its effects
on refolding. Altering the local membrane environment with peptide showed the ability to induce
the conformational refolding in wild type HA as well as two other mutants. Previous work has
shown and suggested the interaction of the fusion peptide with the membrane in order to disrupt
lipid structure and induce lipid mixing and vesicle leakage (Lau et al., 2004; Harrison 2015;
Lorieau et al., 2010; Baquero et al., 2015; White, 2016; Lorieau et al., 2012). We can’t rule out
that the fusion peptide interacts directly with the HA to cause the conformational change by
competing for the pocket. These results taken together indicate that the membrane plays a role in
autocatalysis and will further our understanding for future engineered modular systems.
Whether the phenomenon of autocatalysis extends to other subtypes of HA and other viral
fusion proteins was examined in Chapter 4. Human influenza virus (A/Aichi/69/X31) HA was
seen to have a bimodal response to activation similar to the FPV HA. Indicating that no cell has a
fraction of the HA’s on the surface in a refolded state much like the other subtype the cell shares
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a common mechanism for activation. The similar bimodal response was promising for the modular
system when co-expressing two different subtypes. A modular system expressing ligand induced
H7 HA, HA4xCys, and signal H3 HA, X31-HAcmyc, showed the capability to induce other
subtypes.
Fusion proteins (VSV-G and gp-160) from other viruses were also tested for crosstalk
communication. Fusion protein G, of vesicular stomatitis virus, appeared to activate all the HA coexpressed on the cell. VSV-G, which has a reversible conformational change, co-expressed with a
signal HA, HAcmyc, had a positive c-myc stain even in the absence of a pulse. The reversibility
of VSV-G suggests that the refolding of these proteins is enough to cause the HA to refold. The
refolding of the fusion protein of HIV (gp-160) did not indicate any crosstalk when expressed with
HAcmyc. However, the refolding of HAcmyc due to low pH did indicate crosstalk and the ability
to cause gp-160 to refold and shed the receptor binding domain.
The HA landscape was examined through directed evolution techniques coupled with deep
sequencing analysis revealed key areas of the protein. The expression selection allowed for the
identification of residues that bind the anti-body used in screening. The double selection of
expression as well as activation identified key areas that do not tolerate mutations and contribute
to HA stability. The large number of residues that don’t tolerate mutations clustered around the
fusion peptide region suggests the stability of HA is influenced by the residues in the pocket.
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Recommendations

Crystal Structure of Ligand Inducible HA Mutant.
Determining the crystal structure of the ligand induced mutant would benefit this and future
work. A structure of HA4xCys would greatly benefit the model proposed here of FlAsH binding
the fusion peptide region in its pre-active state and destabilizing it. Structures of both the ligand
bound and unbound sates would provide details and a complete understanding of what causes the
HA to refold. The unbound structure could guide future engineered fusion proteins that could
potentially be induced by more interesting ligands. Maintaining the metastable state after altering
the sequence would provide a better understanding to the refolding mechanism. The structures and
its details would give insight to the dynamics of refolding induced by a ligand.

Directed Evolution for New Stimulus.
Engineering of the fusion peptide region to bind a variety of stimuli could provide novel
sensing functions while not having to retain the fusion capability. The sensing HA co-expressed
with a fusion capable HA, such as wild-type, would create a fusogenic systems that would be
induced in specific environments.
Directed evolution of HA guided by the high throughput sequencing data identifies key
places that tolerate mutations that would be a potential place to engineer ligand binding sites. Novel
ligand-binding sites mutated into regions of HA that will not destabilize the metastable structure
and can promote refolding to the active state upon binding a ligand could be used in the modular
systems. This region must also be accessible for the ligand binding to disrupt the conformation
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allowing the trimer to refold upon binding the ligand. Phage display libraries have been used to
identify peptides capable of binding small ligands (Rozinov and Nolan, 1998), and mapping data
allows us to find potential sites for these peptides. Expression of cloned HA with peptides capable
of binding ligands can be expressed in CHO cells followed by selection of properly folded
metastable states can be done through the mammalian expression assay.
Our tetra-cysteine data suggest an alternative pathway to activation by engineering the
fusion peptide region, this could be a potential site where new peptides can be inserted. Tumor
homing motifs, RGD and NGR, have shown the ability to selectively bind markers in tumor
vasculature (Allen, 2002; Pasqualini et. al., 2000). Both linear and cyclic NGR motifs, such as
GNGRG, CNGRC, and KNGRE, coupled with fluorescent probes have been used to image tumors
(Arap et. al., 2008; Colombo et. al., 2002; Negussie et. al., 2010). Using phage display libraries,
NGR motifs have been found to bind a selectively overexpressed tumor marker, aminopeptidase
N (CD13) (Pasqualini et. al., 2000). Directed evolution can be used randomly mutagenize the
surface of the HA1 region opposed to where the peptide has been inserted and screen for stable
mutants.

Protein Reconstitution in Liposome.
The role of the membrane in activation and extent of fusion was shown in Chapter 3.
Further experiments exploring the role the membrane structure or tension play in the refolding of
HA can be continued. Fusion proteins from transfected CHO can be reconstituted into liposomes
of varying lipid composition and size. The use of different lipids in order to create large unilamellar
vesicles and short unilamellar vesicles to determine the effect of curvature on HA refolding
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(Riqaud and Levy, 2003). Kinetic and refolding data could be monitored with the HA4xCys
mutant. Mixtures of palmitoyloleoyl- and dioleoyl-sn-glycero-3-phosphatidylcholine (POPC and
DOPC), -phosphatidylethanolamine (POPE and DOPE), and cholesterol can be used to form
liposome of varying size and curvature. Previous work has shown that an increase in activation
energies of fusion intermediates is seen when including higher amounts of phosphatidylcholine
(Kasson 2007). The reconstitution of protein in a liposome would be an arduous process but the
result would allow for a very promising application using the modular systems presented in this
project. This data could also be coupled with collaborations with computational groups with
expertise in membrane biophysics.
Vesicles carrying a payload and having reconstituted engineered HA on the surface could
add selectivity to the delivery. An assay similar to the luciferase assay could be applied to monitor
gene transfer to target cells overexpressing markers of human breast carcinoma cells (SK-BR-3
and AU565). The ability to control HA refolding in response to a marker would benefit the
fusogenic modular systems. Selectivity of the delivery system could further be investigated with
mixtures of target and non-target cells to assess the feasibility of using vesicles for future efforts
of drug and gene delivery.
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